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ABSTRACT 
Engineering large viable tissues requires techniques for encouraging rapid capillary bed 
formation to prevent necrosis. A convenient means of creating this micro-vascular network is 
through spontaneous neovascularization, which occurs when endothelial cells (ECs) and 
supportive stromal cells are co-encapsulated within a variety of hydrogel-based extracellular 
matrices (ECM) and self-assemble into an interconnected network of endothelial tubules. 
Although this is a robust phenomenon, the environmental and cell-specific determinants that affect 
the rate and quality of micro-vascular network formation still require additional characterization 
to improve clinical translatability. This thesis investigates how the proteolytic susceptibility of 
engineered matrices effects neovascular self-assembly in poly(ethylene glycol) (PEG) hydrogels 
and provides characterization of changes to matrix mechanics that accompany neovascular 
morphogenesis in fibrin and PEG hydrogels. 
Proteolytic ECM remodeling is essential for the process of capillary morphogenesis. 
Pharmacological inhibitor studies suggested a role for both matrix metalloproteinases (MMP)- 
and plasmin-mediated mechanisms of ECM remodeling in an EC-fibroblast co-culture model of 
vasculogenesis in fibrin. To further investigate the potential contribution of plasmin mediated 
matrix degradation in facilitating capillary morphogenesis we employed PEG hydrogels 
engineered with proteolytic specificity to either MMPs, plasmin, or both. Although fibroblasts 
spread in plasmin-selective hydrogels, we only observed robust capillary morphogenesis in 
MMP-sensitive matrices, with no added benefit in dual susceptible hydrogels. Enhanced 
capillary morphogenesis was observed, however, in PEG hydrogels engineered with increased 
xix 
 
susceptibility to MMPs without altering proteolytic selectivity or hydrogel mechanical 
properties. These findings highlight the critical importance of MMP-mediated ECM degradation 
during vasculogenesis and justify the preferential selection of MMP-degradable peptide 
crosslinkers in the design of synthetic hydrogels used to promote vascularization. 
Matrix stiffness is a well-established cue in cellular morphogenesis, however, the converse 
effect of cellular remodeling on environmental mechanics is comparatively under characterized. 
In fibrin hydrogels, we applied traditional bulk rheology and laser tweezers-based active 
microrheology to demonstrate that both ECs and fibroblasts progressively stiffen the ECM across 
length scales, with the changes in bulk properties dominated by fibroblasts. Despite a lack of 
fibrillar architecture, a similar stiffening effect was observed in MMP-degradable PEG hydrogels. 
This stiffening tightly correlated with degree of vessel formation and critically depended on active 
cellular contractility. To a lesser degree, deposition of ECM proteins also appeared to contribute 
to progressive hydrogel stiffening. Blocking cell-mediated hydrogel degradation abolished 
stiffening, demonstrating that matrix metalloproteinase (MMP)-mediated remodeling is required 
for stiffening to occur. EC co-culture with mesenchymal stem cells (MSCs) in PEG resulted in 
reduced vessel formation compared to fibroblast co-cultures and no change in hydrogel mechanics 
over time. The correlation between matrix stiffening and enhanced vessel formation, and 
dependence on cellular contractility, suggests differences in vessel formation between fibroblasts 
and MSCs may be partially mediated by differences in cellular contractility. Collectively, these 
findings provide a deeper understanding of mechanobiological effects during capillary 
morphogenesis and highlight the dynamic reciprocity between cells and their mechanical 
environment
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CHAPTER I. Introduction 
 
1.1 Motivation, initial hypothesis, objectives, and summary of scientific contributions 
Engineering vascularized viable tissues requires techniques for encouraging rapid 
capillary bed formation to prevent tissue necrosis. Spontaneous neovascularization is a 
convenient means of creating this microvascular network, which occurs when a variety of 
endothelial and supportive stromal cells are co-encapsulated within natural and synthetic 
hydrogel-based extracellular matrices (ECM) (1) and self-assemble into an interconnected 
network of endothelial tubules. This morphogenetic process is controlled by biomolecular 
signaling (2), integrin mediated signaling (3), ECM proteolytic degradation (4, 5), and through 
cellular mechanosensing (6). Although there is a breadth of knowledge characterizing how these 
cellular cues regulate vessel formation, there is still a critical need for translating these 
mechanistic insights into the rational design of tissue constructs that support the formation of 
extensive vascular networks. In particular, the work presented in this dissertation focuses on 
characterizing the interdependence of ECM proteolytic degradation and cell-mediated changes to 
matrix mechanics with the rate of vessel formation in engineered tissues to further our 
understanding of tissue design criteria that support extensive vascularization. 
Matrix metallo-proteinases are widely considered to be the primary class of ECM 
proteinases involved in regulating capillary morphogenesis (4, 5). Previous work in our lab, 
however, has also suggested a plasmin-mediated contribution to angiogenic sprouting in fibrin 
for certain co-culture models (7). Our lab observed accelerated vessel formation in fibrin 
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hydrogels when endothelial cells (ECs) were co-encapsulated with fibroblasts compared to 
mesenchymal stem cells (MSCs) as the supportive stromal cell types and this was correlated with 
plasmin activity (7). A plasmin-mediated contribution to angiogenic sprouting may either be due 
to direct matrix degradation (8) or through plasmin-mediated MMP activation (9). This 
accelerated vessel formation also correlated with reduced barrier function for ECs co-
encapsulated with fibroblasts compared to with MSCs (10, 11). However, despite these previous 
observations, some conflicting reports have demonstrated a lack of plasmin-mediated effects 
during capillary morphogenesis both in vivo (8) and ex vivo (12). As such, there remains a 
knowledge gap in understanding the circumstances and through what mechanism plasmin may 
contribute to capillary morphogenesis. To address this knowledge gap, and based on our 
previous observations, our initial hypothesis was that global plasmin-mediated fibrinolysis in the 
presence of fibroblasts contributes to accelerated capillary network formation and may 
concurrently result in network destabilization and functional immaturity.  
The initial objective of this thesis was to assess whether enhanced ECM proteolytic 
degradation, either by plasmin or MMPs, facilitates accelerated vessel formation. In an effort to 
determine whether global plasmin-mediated fibrinolysis occurs during capillary morphogenesis 
in the presence of fibroblasts, we first investigated whether a combination of active 
microrheology (AMR) and bulk shear rheology to track matrix mechanics across length scales 
could be used to observe ECM degradation over time in fibrin. Additionally, a synthetic 
poly(ethylene glycol) (PEG) based hydrogel with selective proteolytic susceptibility to MMPs, 
plasmin, or both, was used to assess whether direct plasmin-mediated matrix degradation 
facilitates capillary morphogenesis. Results from these studies, however, did not support our 
initial hypothesis; proteolysis did not have a detectable contribution to changes in matrix 
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mechanics in fibrin and plasmin-mediated matrix degradation did not appear to substantially 
contribute to capillary morphogenesis in PEG hydrogels. Increasing PEG-hydrogel susceptibility 
to MMPs did however accelerate vessel formation. These results help illustrate the ubiquitous 
contribution of MMPs for vessel formation, whereas plasmin may only play a substantive role in 
limited circumstances. Moreover, these results inform the design of synthetic matrices intended 
to support capillary morphogenesis by suggesting the importance of focusing research efforts on 
MMP-degradable matrices rather than plasmin- or dual-degradable matrices.  
The work presented in this thesis also provides insights into cell-mediated changes to 
matrix mechanics both in fibrin and PEG. In both hydrogel systems capillary morphogenesis was 
accompanied by progressive hydrogel stiffening rather than our initial expectation of softening 
which would be indicative of degradation. Although there is substantial work investigating the 
effect of environmental mechanics on capillary morphogenesis (13), the converse effect of 
capillary morphogenesis on changes to environmental mechanics is highly understudied. Results 
from this thesis provide insights into cell-population specific contributions to changes in matrix 
mechanics on both the macro and micro scale in fibrin as well as the contribution of essential 
cellular-remodeling processes to changes in matrix mechanics. This work also demonstrates a 
dependence on initial matrix mechanics as well as supportive stromal cell type in PEG on 
affecting degree of stiffening. Continuing to develop an understanding of cellular remodeling 
associated with capillary morphogenesis is essential for designing engineered tissues that support 
extensive vascular network formation. In addition to characterizing cellular remodeling 
processes that occur during capillary morphogenesis in engineered tissues, these results also help 
support the concept of a dynamic and reciprocal relationship between cellular behavior and 
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environmental properties by demonstrating that initial matrix mechanics may alter cellular 
behavior associated with changes to matrix mechanics over time.   
1.2 Overview of dissertation  
Chapter 1 introduces the motivation and the contents of the studies presented in this 
thesis. 
Chapter 2 provides a review of capillary morphogenesis in physiology and in engineered 
tissues. The role of biomolecular signaling, ECM proteolytic degradation, integrin mediated 
signaling, and cellular mechanosensing are covered. Different cell types and matrices that have 
been used for supporting vascular network formation in engineered tissues as well as 
applications in regenerative medicine are also introduced. 
In Chapter 3, micro- and macro-scale hydrogel mechanical properties were tracked over 
time in a model of angiogenic sprouting supported by fibroblasts in fibrin. Active microrheology 
and bulk shear rheology were used to assess whether changes in ECM mechanics could be used 
as a surrogate for assessing proteolytic degradation. Contrary to an expected softening of 
hydrogels over time, a pronounced matrix stiffening was observed. Contributions from ECs and 
fibroblasts both contributed to this observed stiffening effect. This observation has potential 
mechanobiological implications when applying similar models of capillary morphogenesis to 
vascularize tissue constructs in which control of mechanical properties is an important 
consideration. 
In Chapter 4, a proteolytically degradable PEG-based hydrogel crosslinked with 
peptides selectively susceptible to MMPs, plasmin, or both, was used to assess whether plasmin-
mediated matrix degradation facilitates capillary morphogenesis. Robust capillary network 
formation was observed in MMP-selective matrices, but network formation was impeded in 
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plasmin-selective matrices despite robust fibroblast spreading. No morphological differences 
were observed in comparative studies between MMP-selective and dual-sensitive peptide 
crosslinkers. These results suggest MMP-mediated matrix degradation is the dominant 
contributor to capillary morphogenesis in this culture model. We were surprised to observe that 
MMP-selective hydrogels stiffened over time, similar to our observations in fibrin, and this 
phenomenon is further investigated in subsequent chapters. 
Chapter 5 presents initial studies demonstrating that enhancing PEG-hydrogel 
crosslinker susceptibility to MMP-mediated degradation, without altering other hydrogel 
properties results in accelerated vessel formation. A preliminary study comparing morphogenetic 
behavior depending on crosslink identity in a subcutaneous implant model is then presented. 
In Chapter 6, we further characterized our observation that soft MMP-selective PEG-
hydrogels dramatically stiffen over time. Enhanced vessel formation in our softest hydrogel 
formulation correlated with pronounced hydrogel stiffening over time. This effect was dependent 
on active cellular contractility and correlated with increased expression of alpha smooth muscle 
actin. Upregulation and increased deposition of collagen 1 was also correlated with stiffening 
suggesting ECM deposition may contribute to changes in matrix mechanics over time. Like our 
results in fibrin, these findings are contextualized for their mechanobiology implications.  
Chapter 7 presents preliminary studies demonstrating that capillary morphogenesis 
proceeding in the presence of MSCs results in reduced hydrogel stiffening compared to 
fibroblasts in both fibrin and PEG. Because hydrogel stiffening strongly depends on active 
cellular contractility, these results suggest accelerated rates of vessel formation in the presence of 
fibroblasts compared to MSCs may in part be due to differences in contractility.  
6 
 
Chapter 8 provides an overview of the work presented herein, discusses the relevance of 
these findings for the rational design of vascularized tissue constructs, and offers suggestions for 
future work that could be performed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 
 
 
 
Chapter II. Background 
 
2.1 CARDIOVASCULAR PHYSIOLOGY AND DEVELOPMENT 
2.1.1 Cardiovascular physiology 
The cardiovascular system is comprised of the heart, blood vessels, and blood. Its primary 
functions are to transport oxygen, nutrients and endocrine signals to tissues throughout the body 
and for the removal of metabolic waste. Systemic circulation carries oxygenated blood away from 
the heart through the aorta which then branches into arteries and then further into arterioles and 
finally capillaries where diffusive transport between the circulatory system and interstitia occurs. 
Deoxygenated blood is then returned to the heart through venules which merge into veins and drain 
in to the superior and inferior vena cava which empty into the heart (14).  
 Arteries, arterioles, capillaries, venules, and veins each have different architectures (Fig 
2.1, adapted from (15)) but are generally comprised of an internal endothelial layer, extracellular 
matrix components, and an external layer of cells which provide structural support for the blood 
vessel termed mural cells as shown in. Arteries and veins have internal lumen diameters ranging 
from ~30mm for the aorta and vena cava to ~0.1 mm for small arteries and veins, arterioles and 
venules have lumen diameters from 20 - 100 microns and capillaries have lumen diameters 
between 5 – 20 microns (14, 16, 17). Arteries and large arterioles have much thicker walls then 
veins and large venules to resist the high blood pressures they encounter, but the walls of each of 
these types of blood vessels are comprised of 3 layers: the tunica externa, the tunica media, and 
the intima. The tunica externa is primarily collagenous connective tissue and is supported by the 
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external elastic lamina. The tunica media is comprised of smooth muscle cells and elastic tissue. 
The intima is comprised of the endothelium and is supported by the internal elastic membrane. 
These layers provide structural support, regulate blood flow, and are impermeable, whereas 
capillaries are selectively permeable to allow diffusion with interstitial tissues (17). 
2.1.2 Capillary structure and function 
   Capillaries are the smallest vascular structure with diameters comparable to single red 
blood cells (18). As in all blood vessels, endothelial cells form the interior lining of capillaries, but 
in small capillaries a single cell may wrap around the lumen to contact itself. This endothelial layer 
Figure 2.1: Hierarchical organization and structure of blood vessels. The organization and 
direction of blood flow through arteries, arterioles, capillaries, venules and veins is shown with major 
components of blood vessel structure. 
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is ensheathed in a layer of ECM material termed the basement membrane (BM). The BM provides 
physical support, helps regulate cell behavior, and is primarily comprised of collagen IV, laminin, 
heparan-sulphate proteoglycans, and nidogen (19).  Mural cells for capillaries are termed pericytes. 
Pericytes are embedded within the endothelial BM and make multiple forms of contact with ECs 
including cell-cell junctions, notably mediated through N-cadherin, fibronectin-rich adhesion 
plaques, and connexin-43 (20–27). 
Pericytes tend to be located over tight junction regions and contribute to endothelial barrier 
function (28). Pericyte expression of α-SMA, primarily in pre-capillary regions surrounding 
arterioles also suggests their role in regulating capillary bed blood flow (28). The ratio of ECs to 
pericytes ranges from 1:1 to 1:100 depending on tissue type, with the degree of coverage 
corresponding to tissue-specific endothelial barrier function (25). Very low pericyte coverage in 
skeletal muscle, in which capillaries are continuous and maintain baseline barrier function 
excluding solutes larger than ~3 nm diameter (29) suggests their presence may be somewhat 
dispensable in some tissues. Enhanced pericyte coverage is also typically associated with reduced 
EC turnover (30).  
The three types of capillaries are continuous, fenestrated, and sinusoidal. Each type of 
capillary differs in its anatomical location and permeability. Continuous capillaries are most 
common, occurring in skin, muscles, lungs, and brain, and have the lowest molecular permeability. 
Tight junctions between all adjacent endothelial cells helps restrict the paracellular diffusion of 
molecules greater than 4k Da in the blood-brain barrier (31). Fenestrated capillaries have an 
intermediate molecular permeability and are found in endocrine glands, renal glomeruli, and 
intestinal villi. The intercellular junctions of fenestrated capillaries are less well developed, and 
the endothelial cells are fenestrated, containing 50-100 nm wide pores that span the endothelium. 
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Sinusoidal capillaries are discontinuous with gaps large enough for blood cells to pass through and 
are found in the liver, spleen and bone marrow (17). 
2.1.3 Overview of embryonic vasculogenesis and angiogenesis 
The cardiovascular system is the first functional organ to develop during embryogenesis, 
playing an essential role in nutrient transport as well as endocrine signaling (32).  Vasculogenesis 
is defined as the initial formation of a vascular network during embryogenesis in which angioblasts 
arrange into a network of cords and subsequently mature into the primary vascular plexus (33). 
This process occurs following gastrulation with the derivation of hemangioblasts from mesodermal 
cells. Hemangioblasts are multipotent stem cells believed to be precursors for both hematopoietic 
and endothelial cells (34). Hemangioblasts coalesce in the mesoderm to form blood islands. 
Peripheral hemangioblasts in blood islands differentiate into angioblasts and go on to form 
endothelial cells, whereas interior hemangioblasts differentiate into hematopoietic cells. These 
blood islands self-assemble into a network of cords, which become lumenized as angioblasts 
continue to differentiate into endothelial cells forming the primary capillary plexus (32).  
Two mechanisms of lumenogenesis have been observed in in vitro and in vivo models 
termed cell hollowing and cord hollowing.  In the process of cell hollowing, new lumens emerge 
intracellularly through the coalescence of intracellular vacuoles to form a central lumen which 
connects with vacuoles in adjacent cells. During the process of cord hollowing, however, luminal 
space is formed extracellularly in the center of the cord as ECs remain adhered around the 
periphery of the cord (35). Although these processes appear to differ depending on species and 
anatomical location, and have not been well characterized during human development (35), 
processes indicative of cord hollowing have been observed during lumen formation in the 
developing mouse aorta (36). 
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After lumenization, the primary capillary plexus is then reshaped into a hierarchical 
network of vessels and extends throughout the embryo via angiogenic remodeling and sprouting 
angiogenesis. Angiogenesis is broadly defined as either the sprouting of new vessels from the wall 
of preexisting vessels or the remodeling of preexisting vessels resulting in morphological changes 
in size or arrangement (32). Early remodeling processes result in the formation of the primitive 
heart. Angiogenic blood islands join to form endocardial tubes, which during embryonic folding 
fuse to form the primitive heart tube. The primitive heart tube begins to beat on day 22, circulation 
starts on days 27-29. Circulation contributes to continued vascular remodeling. The embryonic 
heart and cardiovascular system resemble the post-natal system by week 30, but they continue to 
grow and develop throughout most of gestation (37).  
2.2 OVERVIEW OF ANGIOGENIC REMODELING  
Angiogenic remodeling includes intussusception, anastomosis, regression and 
arteriogenesis (32). Intussusceptive angiogenesis is the splitting of pre-existing vessels, initiated 
by the formation of pillar-like microstructures that span the endothelial lumen and extend to split 
the lumen into distinct microvessels. Intussusceptive remodeling is particularly important for the 
rapid expansion of the alveolar capillary bed during lung development in the mouse (38). 
Anastomosis, also known as inosculation, is the bridging between lumens of two distinct vessels 
which have come in contact. During anastomosis, the basement membrane of abutting vessels 
degrades at the point of contact, allowing new tight junctions to form between apposing ECs, then 
subsequent selective loss of tight junctions allows lumens to connect (32). During development, 
anastomosis plays an important role in the formation of the aorta (39). Inosculation between 
vascularized tissue constructs and the host vascular system is essential for their efficacy. 
Characterizing, improving, and accelerating  this process is a central goal in tissue engineering 
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(40). Capillary regression occurs when endothelial cells undergo programmed cell death or retract 
and reincorporate into adjacent vessels. Regression often occurs through genetically determined 
processes, with the cessation of blood flow, or reduction of growth-factor mediated maintenance, 
and is important during development and for pruning of redundant vessels (32). Arteriogenesis is 
the circumferential expansion of arterioles to accommodate increased blood flow, and is activated 
by increased fluid shear stress and circumferential wall stress caused by increased blood pressure 
(41). Activation of the endothelium from these physical forces contributes to basement membrane 
degradation, leukocyte invasion, proliferation of endothelial and smooth muscle cells, and 
neointima formation resulting in vessel enlargement (42). 
2.3 ANGIOGENIC SPROUTING 
2.3.1 Overview of angiogenic sprouting 
Blood vessels are normally quiescent in adults but can be induced to undergo angiogenic 
sprouting during wound recovery or because of ischemia. Cytokine signaling induces 
disassociation of pericytes and degradation of the basement membrane resulting in vessel 
hyperpermeability and leakage of blood plasma proteins into the interstitial space creating a local 
proangiogenic provisional matrix rich with fibrin, fibronectin, and vitronectin (3). Accepted 
dogma is that newly forming sprouts are led by a migratory endothelial tip cell, characterized by 
numerous filopodia, which integrates environmental cues to dictate direction of growth. The tip 
cell leads stalk cells, which are highly proliferative and maintain intercellular junctions to ensure 
the stability of the newly forming vessel (43). Vessels return to quiescence as proangiogenic 
signaling subsides, new basement membrane is deposited, and pericytes are recruited  (44). 
2.3.2 Induction of angiogenic sprouting 
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Hypoxia is a potent inducer of angiogenic sprouting. Most transcriptional changes in 
response to hypoxia are regulated by hypoxia inducible factors (HIFs).  HIFs help promote 
endothelial cell proliferation and migration, induce vasodilation and vascular permeability, ECM 
and BM degradation, and recruitment of pericytes to newly forming vessels (45). Notable 
signaling molecules that stimulate angiogenesis include vascular endothelial growth factor 
(VEGF), basic fibroblast growth factor (bFGF), transforming growth factor-α (TGF-α), platelet-
derived growth factor (PDGF), and angiopoietin-1 and -2 (Ang-1 and Ang-2). VEGF is a well-
known EC mitogen and induces tight (46) and adherens (47) junction disassembly. There is a 
large family of VEGF molecules with various isoforms that are either cell membrane-bound, 
ECM-bound, or soluble (48). Thrombin, which converts fibrinogen to fibrin initiating blood clot 
formation, induces hyperpermeability and enhances angiogenesis via an RGD-binding sequence 
that interacts with αvβ3 on endothelial cells (49). Fibroblasts, the most common connective tissue 
cell type, help mediate the pro-angiogenic response, upregulating VEGF under hypoxia (50). 
Fibroblasts secrete angiogenic growth factors that support EC invasiveness and lumen formation 
(51, 52). Ang-1 has been shown to act cooperatively with VEGF to induce angiogenesis despite 
mural cell induced quiescence (53). Intracellular signaling molecules that increase permeability 
and are typically associated with angiogenesis include elevated intracellular calcium and 
activation of protein kinase C (PKC), myosin light-chain kinase (MLCK), Src family kinases, 
and the small GTPase RhoA (54).  
2.3.3 Proteolysis in Capillary Morphogenesis  
Proteinases are key regulators of angiogenic sprouting, contributing to BM and interstitial 
ECM degradation, liberation of ECM sequestered cytokines, and activation of proteolytic and 
bioactive zymogens (4). Matrix metalloproteinases (MMPs), and in particular the membrane-
14 
 
type (MT)-MMPs are critical mediators of matrix remodeling during angiogenic sprouting (7, 12, 
55, 56). MMPs are secreted as inactive zymogens and their catalytic activity is tightly regulated 
(8). MT1-MMP contributes to both direct matrix degradation and intracellular signaling to 
coordinate lumen formation (57). MMP-mediated ECM proteolysis is widely regarded as the 
predominant class of enzymes regulating capillary morphogenesis (4). However, in some 
conditions the serine protease plasmin, which is also activated at the cell membrane, has been 
demonstrated to contribute to capillary morphogenesis (8, 58–60).  
Plasminogen is activated to plasmin by urokinase (uPA) and by tissue plasminogen 
activator (tPA). Plasmin is a serine-protease with broad spectrum tryptic activity capable of 
hydrolyzing fibrin (8). Plasmin is also known to contribute to the activation of certain MMP 
proenzymes (9) and uPA is upregulated in response to bFGF (61). Inhibition of plasmin in an in 
vitro model of capillary morphogenesis in a supraphysiologic concentration of fibrin restricted 
vessel formation (62).  Plasmin binding to αvβ3 on endothelial cells has been shown to induce 
endothelial migration (63). These observations suggest the plasmin/uPA system may play a role 
in capillary morphogenesis either through direct matrix degradation and/or through regulation of 
MMPs, but studies have contrarily demonstrated that normal vascular development and wound 
healing proceed in plasminogen null mice (8) and that plasminogen is not necessary for 
angiogenic sprouting in an ex vivo model (12).   
2.3.4 Mechanosensitive effects in capillary morphogenesis 
 An early demonstration of mechanical forces contributing to capillary morphogenesis 
was the observation of deformations of a flexible silicon rubber substrate coated with Matrigel 
during EC cord self-assembly (6) The laminin receptor α6β1 was essential for endothelial self-
assembly into cord like structures and for Matrigel deformation (6). Endothelial cells have been 
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shown to apply forces to and deform individual ECM fibers during network formation in fibrin 
(64) and in a pseudo-3D network of synthetic fibers (65, 66). Cyclic mechanical strain applied to 
ECs in 2D culture have been shown to promote proliferation through a mechanosignaling 
cascade initiated by vascular endothelial growth factor receptor-2 (VEGFR-2) activation (67). In 
a 3D model of angiogenic sprouting in fibrin with cyclic strain applied to the hydrogels, 
endothelial cells tended to sprout parallel to the direction of applied strain (68). Gradients in 
mechanical properties of hydrogels have also been shown to direct angiogenic sprouting from 
spheroids, with more extensive outgrowth parallel to the direction of the gradient (69). 
2.4 REGULATION OF CAPILLARY MATURITY 
2.4.1 Endothelial barrier function 
Vessel maturity is generally defined as maintaining endothelial barrier function, which is 
the tight regulation of transport across the endothelium. Maturity is conferred by the presence of 
intercellular tight and adherens junctions, a continuous BM, and varying degrees of pericyte 
coverage. Barrier function and angiogenic induction are typically anti-correlated with numerous 
cellular cues affecting both in opposing manners. Transport across the endothelium may either 
occur through the cytoplasm of ECs (transcellular) or through gaps between ECs (paracellular). 
Transcellular transport can occur passively by diffusion of lipophilic molecules, or through ATP-
dependent vesicular or carrier mediated transport (54). Transcellular transport is largely 
regulated depending on cell type and receptor expression profile, whereas paracellular transport 
is regulated by the architecture of intercellular junctions (20). Extravasation of large molecules 
and blood cells typically occurs paracellularly (54). Paracellular barrier function is regulated 
through the formation of tight junctions and adherens junctions. Tight junctions between ECs are 
primarily formed by the protein families of claudins and occludins which mediate cell-cell 
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interactions and are most prevalent in maintaining the blood-brain barrier. Claudins are a large 
family of transmembrane proteins that are essential for tight junction formation. They seal 
paracellular gaps and form ion-specific channels that help regulate paracellular transport (20). 
Adherens junctions are more widely prevalent and in addition to helping control the flux of 
solutes they also function to link the cytoskeleton of neighboring ECs to maintain the structural 
integrity of vessels and control growth through contact inhibition. Homotypic interactions 
between the transmembrane protein family of cadherins mediate this interaction (22). 
Hemodynamic shear stress stimulates adherens junction formation and cytoskeletal remodeling, 
conferring enhanced barrier function (70). In addition to cell-cell junctions amongst ECs, 
endothelial interactions with the ECM and pericytes also help regulate barrier function (6).   
2.4.2 Endothelial-matrix interactions affecting vessel maturity 
Most mature quiescent blood vessels are coated in a continuous basement membrane rich 
in laminins, collagen-IV, perlecan, fibronectin, and nidogens (3). Knockdown of any of these 
BM proteins except nidogens results in embryonic lethality in mice and is correlated with 
vascular permeability (3).  Laminin induces persistent Rac activity in ECs (71) which promotes 
vessel stability and adherens junction formation (72). Collagen-IV helps induce vessel 
quiescence by blocking matrix-metalloproteinase-2 (MMP-2) activity, and upregulating TIMP-2 
expression (73). In general, intracellular signaling molecules associated with vessel maturity 
include protein kinase A (PKA), Epac, sphingosine-1-phosphate (S1P), and the small GTPases 
Rac-1 and cdc42 (54). 
Focal adhesions are mediated by EC integrins binding to ECM proteins and play an 
important role in regulating barrier function. Typically, α1β1 and α2β1 bind to collagen, α3β1, 
α6β1, and α6β4 bind to laminin, α5β1 binds to fibronectin, and αvβ3 and αvβ5 bind to vitronectin 
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(54, 74). ECs invading fibrin clots initially express αvβ3 but lose expression as wounds become 
rich in collagen (75).  Endothelial binding to BM proteins via integrins α3β1 or α5β1 induces a 
less permeable phenotype (76). Angiogenesis occurs much more rapidly in pure fibrin gels than 
in pure collagen-I in vitro, although a combination of both ECM proteins supported nearly the 
same degree of vessel formation as pure fibrin (77). Both ECM proteins are part of the 
provisional matrix ECs experience during wound healing and collagen-I is known to stimulate 
angiogenesis and Rho A activity through integrin signaling, disrupting adherens junction 
formation (71). The interstitial ECM within most tissues in the body is predominately collagen-I, 
and fibroblasts are the predominant source of collagen-I secretion. Integrin signaling between 
fibroblasts and collagen-I provides a negative feedback loop to reduce collagen synthesis when 
its availability is sufficiently high (78).  
2.4.3 Endothelial-pericyte interactions affecting vessel maturity 
Pericyte recruitment to EC vessels stimulates BM deposition which contributes to 
paracellular barrier function (44, 79). Leakiness in tumors is associated with an irregular pericyte 
coat and disorganized basement membrane deposition (80–82), highlighting the importance of 
pericytes in regulating normal vascular function. Direct ECs-pericyte interactions are largely 
mediated by heterotypic N-cadherin interactions, and loss of N-cadherin expression in either ECs 
or pericytes results in poor EC barrier function both in vitro (72) and in vivo (23). EC-pericyte 
interactions induce EC expression of TIMP-2 and pericyte expression of TIMP-3 contributing to 
endothelial tube stabilization. TIMP-2 and -3 inhibit MT1-MMP preventing morphogenesis and 
also provide cues preventing capillary tube regression (83). 
 Well-known pericyte markers include neural-glial antigen-2 (NG2), α-smooth muscle 
actin (α-SMA), desmin, and platelet derived growth factor receptor-β (PDGFRβ) (84–86), and 
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possibly lesser-used markers including calponin, (7) non-muscle myosin, tropomyosin, nestin, 
aminopeptidase A, aminopeptidase N (CD13), and sulfatide (80). Many of these markers are 
shared with other cell types including smooth muscle cells, as such, one of the more widely 
accepted indicators of pericyte identity in addition to biomolecular markers is co-embedment 
within the endothelial BM. 
2.5 MODELS OF VASCULOGENESIS AND ANGIOGENESIS 
In vitro models of capillary morphogenesis broadly fall into the categories of either 
vasculogenic or angiogenic (Fig 2.2).  Capillary networks self-assemble from dispersed 
endothelial cells in vasculogenic models, whereas networks sprout from predefined nodes or 
confluent layers in angiogenic models (87). Early models of vasculogenesis demonstrated that 
endothelial cells seeded on a surface coated with adhesive proteins, or on top of gels made of 
collagen, fibrin, matrigel, or various synthetic substrates, self-assemble into a network of 
Figure 2.2: Examples of angiogenic and vasculogenic models used in this dissertation. (A) 
Endothelial cells (ECs) are coated on Cytodex microcarrier beads which here are embedded in a fibrin 
hydrogel with fibroblasts distributed throughout the matrix. Endothelial cells sprout away from the 
microcarrier creating a capillary like network. (B) ECs and fibroblasts are both distributed in the 
hydrogel and ECs self-assemble into a capillary like network.  Ulex Europaeus Agglutinin I (UEA) is 
a fluorescently labeled lectin that preferentially binds ECs. 4′,6-diamidino-2-phenylindole (DAPI) 
stains all cellular nuclei. UEA-negative nuclei are presumed fibroblasts. 
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capillary like structures (87). In three dimensional models of vasculogenesis, endothelial cells are 
dispersed within various hydrogel matrices and typically require co-culture with a supportive 
stromal cell to form an interconnected capillary like network. Angiogenic models include 
sprouting from monolayers of endothelial cells into a hydrogel either from on top of a hydrogel 
(88) or from coated channels (89), and sprouting from predefined nodes such as aortic ring 
explants (90), spheroids (91), or from EC-coated microcarrier beads (92). 
To date, most studies of capillary morphogenesis have been conducted in biologically 
derived scaffolds such as fibrin, collagen, Matrigel, and hyaluronic acid (93). Although 
biological scaffolds tend to support extensive capillary-network formation, they are difficult to 
precisely engineer and are typically derived from animal sources prompting concerns of batch-
to-batch variation and immuno-rejection. These concerns with naturally derived scaffolds has 
driven interest in synthetic ECM scaffolds, which provide an attractive alternative for clinically 
translatable applications because of low-immunogenicity, tunable material properties, and 
industrial scalability (94). Within engineered hydrogel scaffolds, many endothelial cell types 
have demonstrated the capacity to undergo capillary morphogenesis, including human umbilical 
vein endothelial cells (HUVECs) (7), endothelial colony forming cells (ECFCs) (95), circulating 
endothelial progenitor cells (EPCs) (96), microvascular endothelial cells (MVECs) (97), and ECs 
derived from induced pluripotent stem cells (98). Similarly, numerous stromal cells have 
demonstrated a capacity for supporting vessel formation including multipotent cells from bone 
marrow (56, 99, 100), adipose tissue (10, 101, 102), and cord blood (100), a variety of fibroblasts 
(11, 52, 103, 104), and smooth muscle cells (53, 91, 105). There is little consensus, however, on 
the relative benefits of using certain cell types over others with very few studies directly 
comparing morphogenetic behavior depending on endothelial and stromal cell choices.  
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2.6 APPLICATIONS OF VASCULAR SELF-ASSEMBLY IN TISSUE ENGINEERING 
AND CARDIOVASCULAR DISEASE TREATMENT 
Most tissues require a permeating dense and mature micro-vascular network to supply 
nutrients and remove waste for cell survival. A widespread hurdle in tissue engineering is the 
formation of this functional capillary network within implanted tissue constructs, necessary for 
their long-term viability. Techniques for stimulating the formation of this microvascular network 
broadly fall into the categories of either angiogenic ingrowth and vasculogenic self-assembly 
(40).  Methods that support angiogenic ingrowth often rely on the release of proangiogenic 
growth factors such as VEGF to encourage vascularization (106–108). The formation of a 
vascular bed by angiogenic ingrowth results in the formation of an autologous capillary network, 
which circumvents the issue of implanting allogeneic cells that may elicit an immune response. 
Vasculogenic self-assembly relies on the delivery of an appropriate combination of ECs and 
stromal cell types that cooperatively interact to induce capillary morphogenesis. Vasculogenic 
strategies are convenient for rapid formation of a capillary bed. Implantation of acellular 
hydrogels without pro-angiogenic growth factors often results in little to no vascularization (11, 
106, 109). Vasculogenic strategies, however, are still generally believed to require some degree 
of angiogenic invasion for the implant to become perfused (95), resulting in chimeric vessels 
(110).   
Vascularization strategies are widely relevant for many tissue engineering applications 
including revascularizing ischemic tissues, pre-vascularizing tissues for implantation, and in 
vitro organoid models. There are emerging techniques for fabricating larger tissue constructs 
with vascular conduits on the 100 µm-mm scale (111, 112) allowing for arteriole scale networks. 
Implantation of a biomaterial with 3D printed arteriole scale conduits (113) or the injection of 
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biomaterials that support micro-vessel network formation inducing collateral blood flow (114, 
115) are potential treatment alternatives to autologous or synthetic grafts for arterial bypass 
surgery (116). Intelligent scaffold design is additionally relevant for the fabrication of tissue-
engineered vascular grafts that facilitate the formation of vasa vasorum to enhance graft viability 
(117). Biomaterials that promote capillary morphogenesis without macro-scale conduits also 
present a possible treatment of occluded blood vessels and ischemic pathologies by rapidly 
vascularizing and inosculating with host vasculature to provide collateral blood-flow to bypass 
occluded regions (115, 118).  
Clinically, there is immediate applicability towards vascularization of a variety of tissues 
for implantation including bone grafts to treat bone defects (119, 120) and therapeutic organoids 
that secrete designated biomolecules to replace or supplement patient deficiencies in endocrine 
or immune function (121, 122). Treatment of type 1 diabetes by transplanting pancreatic islets in 
a scaffold to secrete insulin is a well-studied example near clinical translatability (122). 
Recently, significant effort has been invested in vascularizing these therapeutic organoid 
constructs to improve their efficacy, including a PEG-based composite of immuno-isolating and 
angiogenic scaffold materials (123). Moreover, recapitulating cellular cross talk between 
parenchymal and vascular tissues in vitro is essential for accurately constructing tissue models in 
which the parenchyma and endothelium are intimately linked, such as in models of the liver 
(124), kidney (125), and pancreas (126) to study pathological conditions.  
2.7 POLY(ETHYLENE GLYCOL) HYDROGEL DESIGN  
Synthetic ECM scaffolds provide an attractive alternative to natural ECM scaffolds for clinically 
translatable applications because of low-immunogenicity, tunable material properties, and 
industrial scalability (94). Amongst synthetic scaffolds, proteolytically degradable poly (ethylene 
22 
 
glycol) (PEG)-based hydrogel scaffolds have garnished particular interest because of their 
biocompatibility and versatile macromer chemistry allowing tunable hydrogel design (94). The 
PEG-based hydrogels used in this dissertation are formed via a Michael-type nucleophilic 
addition reaction between vinyl sulfone groups on 4-arm PEG molecules (20kDa), and thiol 
groups on terminal cysteine residues of varying peptides (Fig 2.3) (114, 127, 128). Peptide 
crosslinks are proteolytically degradable and can be varied to modulate the rate and specificity of 
degradation without affecting other material properties (128–130). Scaffolds also contain a short 
integrin binding peptide, RGD, which binds numerous integrins and allows for cell adhesion 
(74). Like crosslinks, the identity and concentration of adhesive ligand can be titrated 
independent of other hydrogel material properties. 
Figure 2.3: Reaction scheme for formation of PEG-hydrogels via Michael-type addition. 
Hydrogels used in this work were formed by the conjugation of free cysteines on peptides to vinyl-
sulfone groups on 4-arm PEG molecules via a Michael-type addition reaction. First, RGD is 
conjugated to PEG to functionalize the hydrogels for cellular adhesion. The hydrogels are then 
crosslinked with a proteolytically labile dithiol containing peptide to form a hydrogel. Embedded cells 
can then remodel this matrix via proteolysis during morphogenetic processes. 
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Despite wide-spread interest in PEG-based scaffolds for regenerative medicine 
applications, and various strategies for improving vascularization (106–108), capillary 
morphogenesis remains highly restricted within these scaffolds compared to those derived from 
natural ECM (Fig 2.4), and significant work remains to characterize how vascular self-assembly 
occurs in these materials. The nano-scale amorphous architecture of PEG-based hydrogels rather 
than micro-scale fibrous architecture of most natural ECMs results in differences in cellular 
morphogenesis. There are differences in integrin mediated signaling, mechanical cues from the 
matrix, diffusive transport, and cell migration (129). Key design parameters of PEG hydrogels 
that have been shown to influence capillary morphogenesis include the specificity (131, 132) and 
susceptibility (89, 91) to proteolytic degradation, degree of crosslinking (131, 133), their 
mechanical properties (134), and the presentation of growth factors (107, 108, 121, 123).  
2.8 PREVIOUS WORK COMPARING FIBROBLASTS AND MSCS AS SUPPORTIVE 
STROMAL CELLS 
Comparative studies in which cellular identity and ECM properties are systematically 
varied help illuminate the relative strengths and weaknesses of various culture models. Our lab 
Figure 2.4: Endothelial network formation and overall cell spreading are restricted in PEG-
hydrogels compared to fibrin. Representative images of EC-DF co-cultures after 7 days in either 2.5 
mg/ml fibrin or 27 mg/ml PEG are shown. EC vessels are shown in red stained with UEA, all cellular 
nuclei are shown in cyan stained with DAPI, and all cell bodies are stained in green with phalloidin. 
UEA-negative cell-bodies are presumed fibroblasts. 
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has previously demonstrated that varying the stromal support cell in fibrin hydrogels between 
fibroblasts and bone marrow mesenchymal stem cells (MSCs) results in vessels with varying 
quality. Fibroblasts stimulate more rapid vessel formation than MSCs and these vessels are more 
permeable both in vitro (10) and in vivo (11). Barrier function in the presence of either stromal 
cell type improves over time in vitro, however, at all time points vessels are more permeable 
when cultured with fibroblasts (10).  
MSCs are generally believed to act as pericytes (135, 136) and endothelial cells have 
been shown to stimulate recruitment and differentiation of multipotent mesenchymal cells into 
mural lineages such as smooth muscle cells and pericytes (137). Pericyte recruitment is an 
essential step in stimulating BM formation and in stabilizing nascent vessels (44). Whether 
fibroblasts can act as pericytes however, is less well known. Our group and others have seen 
fibroblasts associate with vessels in a pericyte like manner (103, 118). Fibroblast-secreted ECM 
proteins have been shown to enhance EC vessel formation (52, 138), and fibroblasts are also 
known to stimulate cutaneous (139–141) and pulmonary (142) BM deposition and decrease 
paracellular permeability in lumenized epithelial spheroids (143). We have also seen that both 
MSCs and fibroblasts express α-SMA in our fibrin based angiogenesis assays but only MSCs 
express NG2 (7), suggesting MSCs are more capable of acting as pericytes. EC-pericyte 
crosstalk through NG2 helps stimulate vessel maturity through a β1 integrin dependent pathway 
(144). Our group and others have reported enhanced cadherin expression in the presence of 
MSCs over fibroblasts (10, 72), also suggesting their enhanced capacity to act as pericytes. 
Moreover, MSCs have the capacity to differentiate into a variety of stromal and mural lineages 
(135, 136) which may be essential for maintaining vessel functionality. Differentiation of MSCs 
(145) and trans-differentiation of mural cells (146) into fibroblast phenotypes are well known 
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physiological processes, however the converse is not typically known to occur. Dermal 
fibroblasts are only known to dedifferentiate into a more pluripotent MSC phenotype when 
treated with embryonic cell extract (147), and adventitial fibroblasts may convert into medial 
smooth muscle cells during vascular regeneration (148), but physiological dedifferentiation of 
fibroblasts into MSCs in adult cells has not been reported. 
In addition to differences in pericytic capacity depending on stromal cell identity there 
are also differences in secretory profiles. Fibroblasts, unlike MSCs, upregulate tumor necrosis 
factor α (TNFα) and hepatocyte growth factor (HGF) in the presence of HUVECs (101), 
suggesting an inflammatory wound healing response may also contribute to enhanced 
angiogenesis in the presence of fibroblasts. Myofibroblast differentiation has been associated 
with HGF upregulation (149). In wound healing environments, fibroblasts are known to 
differentiate into myofibroblasts and increase pro-angiogenic cytokine secretion, ECM 
deposition, and increase contractility, which contributes to a proangiogenic response (150–152). 
Although α-SMA expression is often associated with pericyte association, it can also be 
indicative of myofibroblastic differentiation, of which both cell types are capable in a wound 
healing environment (150, 153). 
Our lab has previously demonstrated that fibroblast-mediated sprouting in fibrin is less 
susceptible to MMP inhibition than MSC-mediated sprouting unless serine-proteases are 
additionally inhibited (7). This effect may be mediated either by enhanced serine-protease 
activation of MMPs in fibroblast co-cultures offsetting MMP inhibition, or through a direct 
fibrinolytic contribution of serine-proteases mitigating deficiencies in MMP-mediated ECM 
degradation (7). Plasmin is a key serine-protease implicated in both fibrinolysis (154) as well as 
activation of numerous MMPs (5, 9). HUVECs upregulate the expression of urokinase 
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plasminogen activator (uPA) in the presence of fibroblasts but not MSCs (101), and fibroblasts 
express uPA at a much higher level than MSCs in general (7), implicating the role of plasmin in 
stimulating enhanced fibroblast-mediated invasiveness. Whether plasmin-mediated fibrinolysis 
contributes to angiogenic invasion, however, remains debatable (8, 12, 59, 62). 
Within this thesis I have largely characterized the morphogenetic behavior of endothelial 
cells in the presence of dermal fibroblasts (DFs), with some comparison to lung fibroblasts (LFs) 
and MSCs. Much of our lab’s previous work has used LFs, however, DFs are more 
translationally relevant in that they can be easily obtained autologously (155) without the 
invasive bronchoscopy required to obtain LFs (156). Autologously obtaining MSCs is similarly 
invasive, requiring bone-marrow aspiration (157), with the added difficulty of expanding MSCs 
while maintaining their pluripotent phenotype (158). Characterizing endothelial morphogenesis 
in the presence of DFs provides insight into their morphogenetic behavior while facilitating 
vascularization of engineered tissue constructs. Furthermore, comparison of potential stromal 
cell sources in supporting capillary morphogenesis demonstrates cell-dependent differences, 
which helps inform the rational choice of supportive stromal cells depending on the specified 
application.   
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CHAPTER III 
Sprouting Angiogenesis Induces Significant Mechanical Heterogeneities And ECM 
Stiffening Across Length Scales In Fibrin Hydrogels 
© 2018 Elsevier Ltd. All rights reserved 
3.1 ABSTRACT 
 Matrix stiffness is a well-established instructive cue in two-dimensional cell cultures.  Its 
roles in morphogenesis in 3-dimensional (3D) cultures, and the converse effects of cells on the 
mechanics of their surrounding microenvironment, have been more elusive given the absence of 
suitable methods to quantify stiffness on a length-scale relevant for individual cell-extracellular 
matrix (ECM) interactions. In this study, we applied traditional bulk rheology and laser tweezers-
based active microrheology to probe mechanics across length scales during the complex 
multicellular process of capillary morphogenesis in 3D, and further characterized the relative 
contributions of neovessels and supportive stromal cells to dynamic changes in stiffness over time.  
Our data show local ECM stiffness was highly heterogeneous around sprouting capillaries, and the 
variation progressively increased with time. Both endothelial cells and stromal support cells 
progressively stiffened the ECM, with the changes in bulk properties dominated by the latter.  
Interestingly, regions with high micro-stiffness did not necessarily correlate with remodeled 
regions of high ECM density as shown by confocal reflectance microscopy. Collectively, these 
findings, especially the large spatiotemporal variations in local stiffness around cells during 
morphogenesis in soft 3D fibrin gels, underscore that characterizing ECM mechanics across length 
scales provides an opportunity to attain a deeper mechanobiological understanding of the 
microenvironment’s roles in cell fate and tissue patterning.  
28 
 
3.2 INTRODUCTION 
 Numerous cell types demonstrate differential phenotypic responses and differentiation 
potential depending on the elasticity of the environment in which they reside (159).  Tuning 
substrate rigidity in 2D, ostensibly without altering porosity, diffusive transport, or ligand density, 
alters cell spreading (160, 161), proliferation (162, 163), migration (161, 164), and differentiation 
(165, 166). Despite the interdependence of elasticity with other properties in real tissues, ECM 
mechanical properties also appear to control cell fate in 3D (167, 168). Nevertheless, despite 
considerable interest in the effects of matrix rigidity on cell phenotypes, how cells change the 
mechanical properties of the surrounding ECM, particularly on a microscale, remains poorly 
understood. Moreover, the instructive cue of matrix stiffness has largely been treated as 
unidirectional and static, with measurements of bulk stiffness at a singular initial time point 
correlated with cell fate. In reality, complex morphogenetic processes in 3D involve dynamic and 
reciprocal mechanical cross-talk between cells and the surrounding ECM. 
 ECM stiffness has also been postulated to be an important instructive cue governing 
capillary morphogenesis (169), affecting the magnitudes of contractile forces endothelial cells 
(ECs) exert on their surroundings to control their invasive abilities (170). We have previously 
shown that EC contractile forces are essential for capillary morphogenesis (171), and the rate at 
which ECs deform ECM fibers depends on the initial matrix concentration and correlates with the 
rate at which they form vessel-like structures in 3D (64).  However, different material platforms 
and cross-linking schemes have led to discrepancies in the literature, with some studies suggesting 
softer matrices are more supportive of vascular morphogenesis and others reporting higher 
stiffness yields more invasion. Regardless, across all material platforms, the spatiotemporal 
evolution of ECM micromechanics during angiogenic sprouting remains unclear.  
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 In this study, we exploited a well characterized model of angiogenic sprouting in which 
ECs coated on microcarrier beads invade a 3D fibrin matrix when co-cultured with stromal 
fibroblasts (92, 172). Fibrin is the major component of the provisional matrix in a blood clot (173), 
and thus is a suitable model for investigating the mechanical evolution of ECM during wound 
healing. Fibroblasts secrete pro-angiogenic cytokines and other factors that are essential for EC 
tubulogenesis when co-embedded with ECs in the fibrin matrix, where they can act in a pericyte-
like manner and directly associate with the nascent capillaries (7), or overlaid on top of the gels as 
a monolayer (52, 104). In addition to supporting angiogenesis, fibroblasts play important roles in 
wound closure and healing by increasing contractility and depositing ECM (174), both of which 
effect the elasticity of the matrix (52, 175). 
 Through a combination of shear rheology to track bulk elastic properties and laser-based 
optical tweezers active microrheology (AMR) to quantify elasticity on a length scale relevant for 
individual cells, we explicitly quantified changes in ECM mechanics across length scales, over 
time, and with unprecedented resolution during the complex morphogenetic process of angiogenic 
sprouting in vitro.  Our findings reveal significant mechanical heterogeneities encountered by cells 
on the microscale and demonstrate the extent to which the ECs themselves alter the mechanical 
properties of the surrounding ECM. We further assessed whether pericytic association affects the 
rate and degree to which local ECM stiffening occurs, and determined the effect fibroblasts have 
on the ECM when distant from sprouting microvasculature. Collectively, this study highlights the 
importance of characterizing ECM mechanical properties on an appropriate length scale and over 
time, as initial bulk characterization misses the dynamic and highly varied environment individual 
cells experience.  
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3.3 MATERIALS AND METHODS  
3.3.1 Cell culture:  
Normal human dermal fibroblasts (DFs, Lonza, Walkersville, MD) were cultured in Dulbecco’s 
modified eagle medium (DMEM, Life Technologies, Grand Island, NY) supplemented with 10% 
fetal bovine serum (FBS, Life Technologies) and 1% penicillin streptomycin (Life Technologies) 
and were used up to passage 7. Human umbilical vein endothelial cells (ECs) were either harvested 
from fresh umbilical cords as previously described (172) or purchased from a commercial source 
(Lonza).  Two different sources of ECs were used to ensure robustness of the observed biological 
responses. The ability of these two different sources of HUVECs to sprout in our fibrin-based 
assays was quantitatively equivalent (data not shown).  HUVECs for all experiments were cultured 
in fully supplemented EGM2 (Lonza) and used between passages 2-4. Media for both cell types 
were exchanged 3 times a week and cells were harvested below 80% confluence using 0.05% 
trypsin-EDTA (Life Technologies).  
3.3.2 Fibrin-based capillary morphogenesis assay:  
A three-dimensional cell culture model of capillary morphogenesis was assembled 
following adapted protocols as previously described (92, 172, 176). Briefly, EC-coated microbeads 
were embedded in fibrin gels with DFs either embedded or overlaid on the gel as a monolayer. A 
stock solution of sterilized Cytodex microcarrier beads (Sigma-Aldrich, St Louis, MO) was 
prepared ahead of time by autoclaving in PBS. The day before construct assembly, microbeads 
were coated with ECs by combining 1x104 microbeads with 4x106 ECs in 5 mL of EGM2 in an 
upright T-25 tissue culture flask (Corning Inc, Corning, NY). The flask was incubated for 4 hours 
with periodic agitation every 30 minutes. Afterwards, 5 mL of fresh EGM2 was added, and the 10 
mL suspension of freshly coated beads was transferred to a new T-25 and allowed to incubate 
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overnight in the standard tissue culture position.  The following day, beads were transferred to a 
15 mL conical tube (VWR, Radnor, PA) and allowed to settle by gravity between two washes with 
fresh EGM2. Fibrinogen from bovine plasma (Sigma) was dissolved in serum free EGM2 to 
achieve a final concentration of 2.5 mg/mL clottable fibrinogen upon gelation, and sterile filtered 
through a 0.22 µm PES membrane filter (Merck Millipore Ltd, Tullagreen, Carrigtwohill, Co. 
Cork, IRL). For conditions in which the stromal fibroblasts were embedded within the fibrin gel 
(“embedded”) a suspension of DFs was added to the fibrinogen at a final concentration of 2.5x104 
cells/mL; for the other conditions, an equal volume of EGM2 was added instead. Microbeads were 
added to the solution at 50 beads/mL. Heat-inactivated FBS was added to the solution immediately 
prior to gelation for a final concentration of 5%. Tissue culture dishes were spotted with 40 µL of 
100 U/mL thrombin reconstituted in ddH2O per mL fibrinogen. Dishes were allowed to sit for 5-
minutes before being transferred to incubate at 37 °C for another 25 minutes to allow for complete 
gelation. After gelation, 2 mL of EGM2 per 1 mL of fibrin gel was overlaid for all gels. For 
conditions in which the stromal fibroblasts were cultured on top of the gel (“overlay”), DFs were 
introduced in the overlaid EGM2 at a concentration of 2.5x104 cells/mL of fibrin gel to achieve 
equal DF numbers per gel for both overlay and embedded conditions. For each independent 
experiment, multiple gels were cast for each time point. Gel constructs (0.5 mL total volume) were 
fabricated in 24-well tissue culture plates (Corning Inc) for bulk rheology and network 
quantification assays. For micro-rheology and reflection confocal imaging, gel constructs (1 mL 
total volume) were fabricated in 35 mm glass bottom dishes (MatTek, Ashland, MA).   
 For experiments involving Transwell inserts, fibrin based gel constructs (2 mL total 
volume) were fabricated in the bottom chamber of 6-well Transwell plates (24 mm diameter inserts 
containing 3.0 µm pores; Corning). DFs were cultured on top of the insert, and DAPI staining was 
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used to confirm these cells did not migrate through the porous insert to the gel surface during the 
assay. Because the bottom of the insert would rest on the gel if used as provided, sterilized silicon 
O-rings (MSC, Melville, NY, part # S70-028) were used to space the insert off the top of the gel. 
All tissue constructs were cultured for up to two weeks with media exchanged on day 1 and every 
two days thereafter.  
3.3.3 Fluorescent imaging and quantification of capillary morphogenesis:  
Images were acquired using an Olympus IX81 confocal microscope equipped with a USH-
103OL mercury lamp (Olympus America, Center Valley, PA), a Hamamatsu Orca II CCD camera 
(Hamamatsu Photonics, Hamamatsu City, Japan), and Metamorph Premier software (Molecular 
Devices, Sunnyvale, CA). For visualization of tubules and cell nuclei, co-cultures were fixed with 
Z-Fix aqueous buffered zinc formalin fixative (Anatech, Battle Creek, MI) and stained with a 
rhodamine-conjugated lectin from Ulex europaeus (UEA, Vector Laboratories, Burlingame, CA) 
and 4’,6-diamidino-2-phenylindol (DAPI, Sigma-Aldrich). UEA binds glycoproteins and 
glycolipids specific to endothelial cells. UEA- and DAPI-stained samples were acquired using red 
(Ex: 562 nm, bandwidth: 40 nm; Em: 641 nm, bandwidth: 75 nm) and blue (Ex: 377 nm, 
bandwidth: 50 nm; Em: 477 nm, bandwidth: 60 nm) filter sets, respectively. Network length was 
quantified at days 1, 4, 7, and 14 with all beads imaged at 4x magnification. On day 14, multiple 
images often had to be stitched together to fit the entire network from a single bead. For unbiased 
measurements, the microscope was rastered through each gel and all beads were imaged that were 
far enough away from the edge of plate such that sprouting was unimpinged and did not have 
overlapping networks with a neighboring bead. This resulted in 8-40 beads per condition for each 
independent experiment being quantified, with diminishing beads meeting the criteria as time 
progressed. Three independent experiments (N=3) were conducted for each condition and time 
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point, and the aggregate data from all beads across all 3 independent experiments were presented 
to illustrate the spread in biological response. Total tube length per bead was quantified using the 
Angiogenesis Tube Formation module in Metamorph. The average network length per bead for 
each condition of each independent experiment was then used for statistical analysis. DF 
proliferation in overlay conditions was quantified by taking DAPI images of the DFs in a 
monolayer on top of the gel and manually determining cell density. 
3.3.4 Bulk rheology:  
The bulk mechanical properties of fibrin-based constructs were measured via parallel plate 
shear rheology using an AR-G2 rheometer (TA Instruments, New Castle, DE) equipped with an 8 
mm diameter measurement head and a Peltier stage. Oscillatory shear measurements of 6% strain 
amplitude and a frequency of 1 rad/sec were performed on days 1, 4, 7, and 14 directly in multi-
well tissue culture plates with the rheometer stage maintained at 37 °C. Cell culture media were 
aspirated before measurements, with a small volume left to ensure the gel remained wet. Rheology 
of elastic pre-swollen hydrogels typically involves application of a small normal force prior to data 
acquisition, and/or use of a consistent gap width between the bottom of the sample and the platen. 
However, fibrin’s viscoelasticity precludes use of the former method, while varying degrees of 
cell-mediated gel compaction over time preclude the latter.  Instead, a protocol was developed 
whereby the top platen was lowered until it made initial contact with the hydrogel, followed by 
measurements of shear modulus (G’) taken at 200 µm intervals while closing the gap between 
platen and stage. Gels exhibited a plateau in G’ as the gap was progressively decreased after 
making contact with the gel (Supplementary, Fig 3.6A, B). The peak G’ measured of 3 gap 
heights after making contact with the gel was used as our reported value for the given region of 
interest. One region of interest was interrogated per gel in 24-well plates, and three regions of 
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interest were interrogated per gel in 6-well plates. The measurement head was carefully centered 
in 24-well plates to avoid edge effects contributing to G’ measurements. Comparisons between 
acellular gels in 24 and 6-well plates over time (2.5 cm2 and 9.8 cm2 areas, respectively) were used 
to confirm the robustness of the methods across gels of different sizes (Supplementary, Fig. 
3.6C). Overlay cultures in 6-well plates were also tracked over 14 days to ensure well size did not 
influence observed stiffening behavior (Supplementary, Fig 3.7). Overlay and embedded 
conditions with AMR beads included were also tested to ensure bulk G’ was unaffected by their 
inclusion (Supplementary, Fig 3.8). At least 3 measurements were taken per time point per 
independent experiment.  Three independent experiments were conducted (N=3) and for each 
independent experiment, the gels for all time points were cast from the same stock of reagents. 
3.3.5 Laser tweezers-based Active Microrheology:  
Active microrheology (AMR) was conducted using a dual-laser optical tweezers system, 
as has been previously described (177) and used in the study of capillary morphogenesis (64). 
Briefly, fibrin hydrogels were polymerized as described above within 35 mm glass bottom dishes 
(MatTek, Ashland, MA) with a dispersion of 2 µm carboxylated silica microbeads (Bangs 
Laboratories, Fishers, IN) at a concentration of 0.08% (w/v) throughout the hydrogel. During AMR 
measurements, beads within a volume of approximately 250 x 175 x 30 µm are oscillated at 50 Hz 
by optical forces induced by a focused 1064 nm laser (trapping beam), at an amplitude of 175 nm. 
A stationary 785 nm laser (detection beam) was used to detect each probe particle movement in 
response to the driving force. The oscillation of the input trapping beam and the deflection of the 
detection beam by the microbead are recorded by a pair of quadrant photodiodes (Newport, Irvine, 
CA). These measurements allow for calculation of the complex material response α*. Data here is 
presented as the real component (G’) of the complex shear modulus G*, computed from α*, as 
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previously done (178, 179). AMR measurements were performed on days 1, 4, 7, and 14 (N=3, 
per day, per condition) within a custom-built stage top incubator. The volume measured within 
each measurement location within cell-free samples was chosen randomly, while measurements 
within capillary morphogenesis assays were chosen to be localized around the sprouting 
endothelial cells or proximal to Cytodex beads on day 1. 
3.3.6 Confocal Reflection Microscopy:  
Reflection confocal stacks were acquired prior to AMR measurement of each sample. 
Confocal microscopy was conducted using a Fluoview 1200 system (Olympus), integrated into 
the optical tweezers microscope.  Image stacks were imaged using the 488 nm laser line with a 
depth of approximately 60 µm and step size of 1 µm. For z-projections, stacks were trimmed to 
remove effect of glass aberration in reflection confocal and in order to keep a consistent number 
of planes for each z projection. Images were acquired using the same objective as for AMR; 
1.45NA 60X TIRF Oil Objective (Olympus). 
3.3.7 Statistics:  
Varying statistical methods were performed depending on the nature of the data analyzed 
and are indicated as appropriate on the figure captions. For analyzing network length, the average 
sprout length per bead from 8-40 beads per time point per replicate was considered for statistical 
analysis in comparing conditions. Linear regression was used for analyzing network length data 
for embedded and overlay conditions. For analyzing bulk rheology data, the average bulk modulus 
from 3-6 ROIs per time point per replicate was considered in comparing conditions. 
Heteroscedastic 2-tail t-tests were used to verify overlay and Transwell conditions had equitable 
sprouting on any given day, that AMR beads do not influence bulk G’ or sprouting, and that culture 
well size does not influence bulk-G’. One-way ANOVA was used to determine differences in bulk 
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mechanical properties and followed with Tukey HSD post-hoc testing if differences were detected. 
Mann-Whitney U tests with a Bonferroni correction were performed between pairs of aggregate 
AMR data. 
3.4 RESULTS 
3.4.1 DFs stimulate EC neovessel formation when overlaid or embedded in fibrin matrices: 
 ECs cultured on microcarrier beads embedded in fibrin gels of physiological concentration 
(180) undergo a complex 3D morphogenetic program that results in vessel-like structures radiating 
from the microcarrier bead when co-cultured with a variety of stromal cells (7, 92, 101). Here we 
demonstrate that normal human dermal fibroblasts (DFs), a clinically relevant and potentially 
autologous cell source, similarly support angiogenic outgrowth of ECs from microcarrier beads.  
DFs were either embedded or overlaid on the fibrin matrix to better elucidate the relative 
contributions of DFs versus EC tubules on the micro- and macro-rheological properties of the gel. 
Cartoon schematics of these two culture models are shown (Fig. 3.1A), along with representative 
images of the typical morphogenetic progression for both culture models (Fig. 3.1B).  (Day 1 
images reveal approximately comparable levels of EC confluence on the Cytodex beads achieved 
via the methods described.)   Quantification of these types of images over a 14-day time course 
reveals an increase in the total length of the vessel-like networks for both conditions, with 
aggregate data from all beads across each independent experiment shown to illustrate the spread 
in the observed biological response (Fig. 3.1C). The average total network lengths for the 
embedded culture model were consistently higher than the overlay model after day 1, but this 
increase was not statistically significant. Additionally, inclusion of AMR beads did not affect the 
rate of network formation (Supplementary, Fig 3.9). Over the duration of the culture period, the 
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average network length per bead scaled across multiple orders of magnitude with the variance 
scaling accordingly. Data were log transformed and analyzed with a general linear model. The 
resulting model is: Log(Network Length) = 3.776*Log(Day). The single regression parameter is 
Figure 3.1: DFs induce EC branching morphogenesis when overlaid or embedded within 3D 
fibrin matrices. A) Schematic representation of the capillary morphogenesis assay. The “Overlay” 
condition involves culturing DFs on top of the fibrin gel, while the DFs are distributed throughout the 
fibrin gel in the “Embedded” condition. B) Representative images from each condition over a 14 day 
time course. UEA and DAPI staining indicate ECs and total cell nuclei, respectively. Scale bar = 500 
µm. C) Quantified network lengths vs. time for both Overlay and Embedded conditions (8-40 beads 
assessed per replicate, N=3 per condition, per time point). A general linear model resulted in 
Log(Network Length) = 3.776*Log(Day), p < 0.0001, R2 = 0.988. Boxed regions show median and 
interquartile range (IQR) of aggregate data, whiskers show range within 1.5 IQR. 
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highly significant with p < 0.0001 and the model has an R2 value of 0.988, demonstrating that 
vessel growth was exponential in time.  
3.4.2 Acellular fibrin gels are mechanically stable over 14 days as assessed by macro-rheology 
and AMR:  
 To characterize the bulk rheological properties of both acellular (pre-swollen) and cell-
seeded fibrin constructs, we devised a new method described in the Supplemental Materials and 
Methods.  Cartoon schematics illustrating the relative scale of bulk rheology compared to AMR 
are presented in Fig 3.2A to illustrate the large difference in resolution between the two techniques. 
Bulk rheology showed acellular fibrin gels are mechanically stable, maintaining a nearly constant 
(time-invariant) G’ of 119 ± 19 Pa (mean + st. dev. from all trials and days) over  
the course of the culture period. Moreover, the inclusion of Cytodex (Fig 3.2B) and/or AMR beads 
(Supplementary, Fig 3.9) did not influence the bulk properties of the gel. Additionally, agreement 
between G’ measurements of gels cast in multiple well sizes illustrates the validity of the method 
developed, independent of gel size (Supplementary, Fig 3.6).  Moving forward, we have used G’ 
(the elastic component of the shear modulus) interchangeably with the more colloquial term 
“stiffness.” 
AMR measurements of acellular fibrin gels, both with and without Cytodex beads, 
exhibited notable stiffness heterogeneity spanning nearly two orders of magnitude (Fig 3.2C; min 
value of 8 Pa, max value of 933 Pa across all conditions and time points shown on the graph). 
Repeatedly, the mean stiffness of these cell-free systems was slightly higher at Day 1, as compared 
to Days 4, 7, and 14 (p<0.05, for both +/- Cytodex beads). However, comparisons of local G’ 
values across the later time points were not statistically different from one another, illustrating the 
mechanical stability of these acellular fibrin gels at the microscale consistent with bulk rheology.  
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Figure 3.2: Bulk rheology and AMR of acellular fibrin gels reveal the gels are mechanically stable 
over 2 weeks in culture conditions. A) Schematic diagram of methods used to quantify stiffness in 
bulk using parallel plate rheology (left) and at the microscale using active microrheology (right). B) 
Bulk rheology over 14 days with (red) and without (blue) Cytodex beads. (N=3, per condition, per 
timepoint). One-way ANOVA of G’ +/- Cytodex beads yielded a P value of 0.93. C) Microrheology 
over 14 days with and without Cytodex beads (aggregate data, N=3 independent samples, with 
nAMRbeads>150 per time point, per condition). Boxed regions in panels B and C show median and 
interquartile range (IQR) of aggregate data, whiskers show range within 1.5 IQR. The asterisk above 
Day 1 indicates significant differences (p<0.05) relative to all other time points for both conditions (+/- 
Cytodex beads). D) Microrheology data from (C) plotted as a function of distance from the edge of the 
Cytodex bead. E,F) Confocal reflection of the fibrin meshwork without and with Cytodex beads (Scale 
bar = 20 µm). 
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Furthermore, the presence of the Cytodex beads did not appreciably affect the distribution of local 
stiffness, as demonstrated by plotting G’ values at increasing distance from the Cytodex beads (Fig 
3.2D). Additionally, confocal reflection images near Cytodex beads were indistinguishable from 
gels without cytodex beads, illustrating that Cytodex beads do not disrupt the fibrillar architecture 
(Fig 3.2E, F). 
3.4.3 Bulk rheology reveals tissue constructs stiffen over time during morphogenesis: 
 Fibrin gels with DFs either overlaid or embedded demonstrated significant stiffening over 
time, with overlay conditions stiffening more rapidly than embedded conditions (Fig 3.3A). 
Controls in which DFs were included but Cytodex microcarrier beads were not coated with ECs 
demonstrate similar bulk stiffening behavior over time (Fig 3.3B). Scaffolds with DFs embedded 
stiffened ~2-fold to a final G’ of 253 ± 27 Pa, while scaffolds with DFs overlaid stiffened ~3.3-
fold to a final G’ of ~394 ± 43 Pa over the course of 2 weeks. Heteroscedastic 2-tail t-tests were 
used to verify no significant differences occurred between G’ measured for any given culture 
model and day compared to its respective DF Only control (Fig 3.3A, 3.3B). In addition, 
experiments in which DFs were cultured on Transwell inserts, and then removed for gel 
rheological measurements, showed that construct mechanical properties did not significantly  
change over a 14-day time course in the absence of DFs, even when ECs were included in the 
culture and tubulogenesis occurred (Fig. 3.3C). Lack of contact of the DFs with the fibrin construct 
via the Transwell did not adversely affect capillary sprouting, as revealed by the equivalent total 
network lengths (Fig. 3.3D).  Together, these data demonstrate that DFs dominate the bulk 
stiffening of the scaffolds, while the ECs undergoing morphogenesis did not significantly affect 
the bulk mechanical properties of the constructs in this assay. 
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Figure 3.3: Bulk rheology reveals an increase in stiffness with time during morphogenesis. Parallel 
plate rheology of (A) bead assay in both the Overlay and Embedded conditions, (B) fibrin constructs 
with only DFs (no ECs) either overlaid on top of the gel or embedded within, and (C) a bead assay and 
a fibrin construct with DFs located on a Transwell (N=3 independent experiments for each time point 
and condition).  Asterisks in (A) and (B) indicate statistical differences from all other time points for a 
given assay type (p<0.05). D) Quantified network lengths between the Overlay condition and Overlay 
with DFs on a Transwell (multiple ROIs assessed per sample, N=3, per condition, per time point). There 
were no statistical differences between Transwell and Overlay conditions for any given day. Boxed 
regions show median and interquartile range (IQR) of aggregate data, whiskers show range within 1.5 
IQR.  
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3.4.4 Capillary morphogenesis is accompanied by dynamic spatiotemporal changes in local 
ECM stiffness and organization: 
 Results from selected AMR measurements for both overlay and embedded conditions 
proximal to the endothelial sprouts show that ECM micro-stiffness changed considerably in both 
space and time during capillary sprouting (Fig 3.4A, 3.4B, phase). In some cases, AMR beads in 
close proximity reported G’ values that differed by as much as 5-10x within only a few microns in 
the same ECM (Fig 3.4, arrows).  Matched maximum intensity confocal reflection z-projections 
(Fig 3.4A, 3.4B, confocal reflection) demonstrated how the ECM was simultaneously remodeled. 
At early time points (Days 1 and 4), a typical fibrin mesh was detected proximal to the ECs. 
Stepping through assembled z-stacks revealed a distinct high contrast fibrillar architecture 
surrounding Cytodex beads on Day 1 for both the overlay (Supplementary, Video 3.1) and 
embedded (Supplementary, Video 3.2) culture models; this architecture is a hallmark signature 
of fibrin’s microstructure. In the embedded model, however, the ECM was already changing 
spatially around the embedded fibroblasts.  By Day 14, this fibrillar meshwork was replaced with 
a diffuse signal indicative of remodeling by the cells at later time points (Days 7 and 14). The 
fibrous structure was difficult to resolve near capillaries in the overlay conditions 
(Supplementary, Video 3.3), and throughout the dish for embedded cultures (Supplementary, 
Video 3.4). Interestingly, changes in pericellular ECM architecture over time did not necessarily 
correlate with regions of elevated stiffness as measured by AMR in the same locations. This was  
particularly evident in the Day 7 overlay condition, where punctate stiff areas are found both in 
and out of the remodeled area, though generally appears elevated near sprouts.   
3.4.5 AMR quantitatively reveals significant local ECM stiffness heterogeneities during 
capillary morphogenesis: 
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  AMR measurements were conducted for both the overlay and embedded conditions in 
triplicate, and the results are shown in aggregate (Fig 3.5A). Generally, there was an increase in 
average micro-stiffness over time. As early as Day 1, the embedded condition showed a broader 
range of G’ values as compared to the overlay condition, with both conditions showing an orders- 
 
Figure 3.4: Capillary morphogenesis is accompanied by dynamic spatiotemporal changes in local 
ECM stiffness and organization. Selected stiffness maps generated using AMR and corresponding 
confocal reflection maximum intensity z-projections for the (A) Overlay and (B) Embedded conditions. 
Z-projections were created from 60 µm z-stacks with a step size of 1 µm, with those planes affected by 
distortion from the coverglass trimmed out prior to z-projection. Scale bar = 20 µm for brightfield 
images and 20 µm for reflection confocal z-projections. Arrows added emphasize areas where there is 
close proximity of stiffness heterogeneity, especially in the context of areas that appear different from 
the fibrous structure of fibrin. Please note the color map for G’ saturates at 300 Pa. Stiffness values for 
individual beads reporting stiffness above 300 Pa are annotated on the beads. 
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of-magnitude distribution. Within the embedded condition, this heterogeneity was observed as   
early as Day 1. Consistent with acellular gels (Fig 3.2C), average local stiffness in the overlay 
condition decreased slightly between Days 1 and 4 (p<0.05), and by Day 14 was similar on average 
to the embedded condition.  To assess the effects of DFs on the peri-endothelial stiffness, AMR 
was conducted in fibrin gels containing only fibroblasts in both the overlay and embedded 
conditions (Fig 3.5B). In the embedded case, the effects of fibroblast remodeling were evident 
(increasing G’) by Day 7, whereas in the overlay case, no such effect was observed. In fact, overlay 
gels softened at Day 14 (p<0.05, compared to all other days), an effect not observed with bulk 
rheology (Fig 3.3B).  
 To further analyze the spatial distribution of stiffness observed in both the overlay and 
embedded conditions, AMR measurements were classified as either near or far, based on the 
proximity of each probe particle (<50µm or >50µm, respectively) to the nearest endothelial tubule 
(Fig 3.5C). Within these conditions, G’ near is significantly greater than G’ far at all time points, 
except for Day 1 of the embedded case (Mann-Whitney Test, p<0.05). This indicates that the 
effects of endothelial vessel stiffening of the ECM are concentrated proximal to the vessel,  
with the effect dissipating with distance. Plots of G’ as a function of probe bead proximity to the 
ECs (Fig 3.5D) show that in the overlay case stiffening is concentrated in a region approximately 
Figure 3.5: AMR quantitatively reveals significant local ECM stiffness heterogeneities during 
capillary morphogenesis.  A) Microrheology proximal to the sprout tips in both the Overlay and 
Embedded conditions (aggregate data, N=3 per condition, per timepoint). B) Microrheology in fibrin 
constructs only containing DFs (no ECs) either overlaid on top of the gel or embedded within (aggregate 
data, N=3 independent samples, with nAMRbeads>150 per time point, per condition). C) Microrheology 
from (A) segregated into two classes, near or far, based on distance from endothelial cells (<50 µm or 
>50 µm, respectively). For panels A-C, asterisks indicate statistical differences between groups 
(p<0.05) Boxed regions show median and interquartile range (IQR) of aggregate data, whiskers show 
range within 1.5 IQR. D) Microrheology data from (A) plotted as a function of probe bead proximity to 
the ECs.  
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within 50 µm of the ECs and increases over time. In contrast, the stiffness topography is more 
heterogeneous at all time points in the embedded case. 
3.5 DISCUSSION 
 Branching morphogenesis is a complex phenomenon that occurs throughout the life of all 
metazoan organisms (181), and there is strong evidence that ECM mechanics and cell-generated 
forces play important roles in shaping the organization (and disorganization) of both normal and 
diseased tissues (182, 183).  Studies using biomimetic materials have shown that matrix stiffness 
regulates cell fate in 2D (165) and 3D (167). More recent studies have shown the ECM’s 
mechanical regulation of cell behavior goes well beyond initial bulk material properties (e.g., 
compressive, tensile, shear moduli), with strong evidence that stress relaxation (184), fibrillar 
architectures (65), mechanical patterns/gradients (185, 186), and dynamic changes in mechanical 
properties (187–189) all play significant roles.  To better understand the mechanical influence of 
a natural ECM on a complex morphogenetic process in 3D, we applied a laser tweezers-based 
active microrheology method and traditional parallel plate shear macrorheology to a well-
established and biologically relevant 3D fibrin-based co-culture model of capillary 
morphogenesis, and tracked the spatiotemporal evolution of the micro- and macro-scale shear 
elastic modulus during the formation of an extensive microvascular network. 
 AMR revealed mechanical micro-heterogeneities within acellular fibrin-based matrices, 
with G’ values spanning an order of magnitude within each gel. This microscale heterogeneity 
increased in the presence of cells and with time in culture, coincident with an overall increase in 
the bulk G’ values of the tissue constructs.  Experiments to dissect the cellular origins of this 
increased stiffness revealed that the supportive DFs largely accounted for the observed increases 
in the bulk mechanical properties of the ECM, as DF monocultures lacking ECs also increased 
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their bulk mechanical properties with time in culture.  Additional experiments in which DFs were 
cultured on a Transwell insert placed on top of the gel revealed that the bulk mechanical properties 
of gels not in physical contact with DFs did not increase.  Equivalent EC sprouting occurred when 
DFs were in direct contact with the gel or on a Transwell.  Because we have previously shown that 
sprouting is deficient in the presence of fibroblast-conditioned media (171), these experiments 
show that reciprocal cross-talk between ECs and DFs necessary for morphogenesis still occurs 
when the latter are cultured on Transwells.   
 While the bulk mechanical property changes were largely attributable to the DFs, AMR 
revealed that ECs undergoing sprouting angiogenesis also progressively stiffened the ECM as they 
invaded. Significant increases in the micro-stiffness of the ECM occurred within 50 µm (“near”) 
of the sprouting vessel-like structures, regardless of whether DFs were overlaid or embedded in 
the matrix. The AMR experiments in the overlay conditions were particularly indicative of the EC-
induced local stiffening because the DFs were located on top of the gel a fixed distance away from 
the z-plane (> 500 µm) in which the EC-coated beads tend to settle and in which our AMR 
measurements were taken. The increased heterogeneity of G’ values with time in the “near” region 
proximal to the vessel-like structures in the overlay conditions was also likely due to ECs. ECs 
apply traction forces (64, 170) and deposit new matrix (190) during capillary morphogenesis, both 
of which would be expected to locally stiffen the ECM.  
 In addition to our AMR measurements, we observed changes in ECM architecture during 
morphogenesis via confocal reflection microscopy. Previous studies have shown that EC tubules 
invading a fibrous collagen ECM deposit new collagen matrix (appearing specular as opposed to 
fibrillar) proximal to the lumen as EC tubules grow (190). The ECM’s appearance proximal to 
vessels in our culture models (Supplementary Videos 3 and 4) was consistent with these previous 
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findings.  What has not been clear is how such changes affect local stiffness over time.  Our AMR 
results show that local stiffness heterogeneity increased over time in culture, an effect localized to 
EC tubules in the overlay culture, but ubiquitous in the embedded cultures that contain an 
increasing population of DFs. In some cases, stiffness distal to EC tubules and located in fibrous 
ECM increased to values similar to those found proximal to EC tubules in specular ECM. 
Furthermore, this distal effect was limited in extent for the overlay conditions; beyond ~50 µm 
from the tubule surface, stiffness values were similar to those measured by bulk rheology and 
AMR of acellular gels. Therefore, areas of obvious matrix remodeling did not necessarily coincide 
with regions of elevated stiffness or even the greatest stiffness heterogeneities. This observation 
casts important limitations on methods that correlate mechanical properties with fiber architecture 
(191) or rely on quantification of fiber deformations (192). 
 In the context of vascular morphogenesis, inconsistencies regarding the roles of ECM 
mechanics remain in the literature. Early evidence demonstrated that mechanical cues directly 
impact tubulogenesis, with softer gels better able to support capillary morphogenesis in 2D (193, 
194). In 3D cultures, angiogenic process extension was attenuated in fibrin gels whose mechanical 
properties were manipulated by adding exogenous factor XIII to form additional cross-links (195).  
We previously demonstrated that increasing fibrin’s bulk mechanical properties by increasing 
fibrinogen concentration beyond the physiologic provisional clot concentration used here (~2.5 
mg/mL) (180) results in significant reductions in angiogenic sprouting not only in vitro (172) but 
also in vivo (196); however, sub-physiologic concentrations yield overly soft gels that slowed 
angiogenic invasion due to reduced resistance to cell-generated traction forces (64).  Efforts to 
decouple ECM stiffness from other cues using glycated collagen matrices have demonstrated that 
stiffer ECM promotes increased angiogenic outgrowth, invasion, and branching, independent of 
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changes in matrix density (197, 198). Similarly, angiogenic invasion of ECs was increased in 
collagen gels cross-linked with transglutaminase to increase the stiffness without affecting the 
concentration (199). However, other studies have reported that increased stiffness induced by 
collagen glycation attenuates vessel morphogenesis (200, 201).   
 Because of the limitations of natural ECMs and the inconsistencies in the literature, we 
(and many others) have turned to synthetic material platforms in an effort to decouple the 
mechanical and chemical effects of the ECM and thereby differentiate the contributions of 
mechanical cues in isolation. In such systems, softer, less cross-linked gels susceptible to cell-
secreted proteases were better able to support the formation of vessel-like networks in vitro (114, 
202); the identity of the degradable peptides was a bigger influence than the starting mechanical 
properties of the gels on the formation of functional microvasculature in vivo (114). However, 
engineered hydrogels lack key features of native ECM, which is typically fibrillar, macroporous, 
heterogeneous, mechanically anisotropic, and is actively remodeled by the cells that reside within 
it.  The amorphous nature and mechanical homogeneity of synthetic gels are essential for their 
utility in 3D traction force microscopy (203), but questions remain regarding their physiological 
relevance for addressing mechanistic questions. 
 Our findings underscore the importance of characterizing across length scales when 
deciphering the roles of ECM mechanics on morphogenesis in 3D. Bulk rheology was useful for 
establishing ensemble averaged mechanical properties and quantifying the large degrees of stromal 
cell-mediated matrix remodeling with a relatively accessible technique.  Understanding bulk 
properties is important for handling of tissue constructs and regenerative medicine applications.   
By contrast, AMR was useful for the precise spatiotemporal quantification of ECM mechanics on 
subcellular length scales during 3D capillary morphogenesis in soft fibrin matrices. Similar AMR 
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measurements have also revealed enormous heterogeneity in the micromechanical properties of 
type-I collagen gels (204).  Interestingly, in these collagen gels, local cell-mediated stiffening 
requires both myosin-mediated traction forces (204)  and active proteolysis via MMPs (205).  
Future work will address if the wide spatiotemporal variations in ECM stiffness observed during 
capillary growth and invasion in soft fibrin gels translate to other natural materials (of different 
concentrations), and if they directly influence phenotypic bifurcations (i.e., cell fate decisions), 
including the induction of vessel branching or the guidance of vascular invasion.  
 
3.6 SUPPLEMENTARY FIGURES AND VIDEOS 
 
 
 
Figure 3.6: Acellular fibrin gels in culture plates reach consistent plateau value for G’ and 
are consistent across well sizes. A) Schematic illustrating gap height from bottom of sample to 
measurement head. B) Shear modulus as a function of gap height is shown as the rheometer 
measurement head was progressively lowered onto acellular fibrin gels cast in 24-well plates. A 
plateau value of ~110 Pa was quickly reached after the measurement head made contact with the 
gels and was consistent over hundreds of microns before gradually decreasing. (Aggregate data 
shown, N=4) C) Shear modulus is consistent between 24-well (2.5 cm2) and 6-well (9.8 cm2) plates 
across time. One-way ANOVA resulted in p = 0.60 between all conditions and time points.  
(Aggregate data shown, N=3, per condition, per time point)  
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Figure 3.7: Culture well size does not influence stiffening behavior of overlay conditions. 
Bulk G’ on days 1, 7, and 14 was unaffected by the size of well in which cells were cultured, as 
assessed with t-tests between matching conditions. (Aggregate data shown, N=3 for all conditions) 
 
 
 
Figure 3.8: Inclusion of AMR beads does not influence bulk G’ of cell cultures on Day 7. Bulk 
G’ was unaffected by the inclusion of AMR beads for either co-culture model, as assessed with t-
tests between matching conditions. (Aggregate data shown, N=3 for all conditions)  
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Figure 3.9: Inclusion of AMR beads does not influence capillary network formation at Day 
7. Average network lengths were unaffected by the inclusion of AMR beads for either co-culture 
model, as assessed with t-tests between matching conditions. (Aggregate data shown, N=3 for all 
conditions) 
 
 
 
 
 
Figure 3.10: Inclusion of Cytodex and/or AMR beads does not influence the bulk properties 
of acellular gels over time. No significant differences in bulk G’ were observed between any 
condition across all time points. One-way ANOVA resulted in p = 0.91 between all conditions and 
time points. (Aggregate data shown, N=3, per condition, per time point) 
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Video 3.1: Day 1 Overlay Condition - Reflection confocal z-stack.  EC-coated cytodex bead 
within fibrin matrix highlighting the structure of the fibrin matrix prior to sprouting when DFs are 
in the overlay configuration.  
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Video 3.2: Day 1 Embedded Condition - Reflection confocal z-stack. EC-coated cytodex bead 
within fibrin matrix highlighting the structure of the fibrin matrix prior to sprouting when DFs are 
in the embedded configuration.  
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Video 3.3: Day 14 Overlay Condition - Reflection confocal z-stack. EC sprout within fibrin 
matrix highlighting the structure of the fibrin matrix following 14 days of growth with DFS in the 
overlay configuration. 
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Video 3.4: Day 14 Embedded Condition - Reflection confocal z-stack. EC sprout within fibrin 
matrix highlighting the structure of the fibrin matrix following 14 days of growth with DFS in the 
embedded configuration.  
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CHAPTER IV 
Deciphering The Relative Roles Of Matrix Metalloproteinase- And Plasmin-Mediated 
Matrix Degradation During Capillary Morphogenesis Using Engineered Hydrogels 
© 2019 Wiley Periodicals, Inc. 
4.1 ABSTRACT 
Extracellular matrix (ECM) remodeling is essential for the process of capillary 
morphogenesis. Here we employed synthetic poly(ethylene glycol) (PEG) hydrogels engineered 
with proteolytic specificity to either matrix metalloproteinases (MMPs), plasmin, or both to 
investigate the relative contributions of MMP- and plasmin-mediated ECM remodeling to vessel 
formation in a 3D-model of capillary self-assembly analogous to vasculogenesis. We first 
demonstrated a role for both MMP- and plasmin-mediated mechanisms of ECM remodeling in 
an endothelial-fibroblast co-culture model of vasculogenesis in fibrin hydrogels using inhibitors 
of MMPs and plasmin. When this co-culture model was employed in engineered PEG hydrogels 
with selective protease sensitivity, we observed robust capillary morphogenesis only in MMP-
sensitive matrices. Fibroblast spreading in plasmin-selective hydrogels confirmed this difference 
was due to protease preference by endothelial cells, not due to limitations of the matrix itself. In 
hydrogels engineered with crosslinks that were dually susceptible to MMPs and plasmin, 
capillary morphogenesis was unchanged. These findings highlight the critical importance of 
MMP-mediated degradation during vasculogenesis and provide strong evidence to justify the 
preferential selection of MMP-degradable peptide crosslinkers in synthetic hydrogels used to 
study vascular morphogenesis and promote vascularization. 
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4.2 INTRODUCTION 
The microvasculature is essential to the normal function, maintenance, and repair of 
nearly all tissues. This complex network continuously evolves to meet changing demands of 
tissues. Throughout this process, the extracellular matrix is continuously remodeled, making 
extracellular proteolytic systems central to the regulation of capillary morphogenesis (5, 206).  
There are a wide range of proteolytic systems implicated in the formation of new vessels (206). 
Matrix metalloproteinases (MMPs), and in particular the membrane-type (MT)-MMPs, have 
emerged as critical mediators of matrix remodeling not only in collagen but also in fibrin (7, 12, 
55, 56). However, the serine protease plasmin, which is also activated at the cell membrane, may 
provide an alternative mechanism for proteolytic remodeling, and in some conditions, is 
necessary for capillary morphogenesis in fibrin (58–61). The relative importance of these 
systems in capillary morphogenesis therefore remains an open question.  
In 3D models, endothelial cells co-cultured with supporting stromal cells undergo 
capillary morphogenesis (7). We have observed that stromal cell identity modulates the 
contribution of the plasmin pathway to this process in fibrin (7, 101) and have correlated these 
observations with differences in the extent of vessel formation, morphology, and permeability 
both in vitro (7, 10) and in vivo (11). These findings suggest the mechanisms of proteolytic 
remodeling during vessel formation may dictate functional properties of the resulting capillary 
network, which has important implications for the design of synthetic biomaterial scaffolds that 
support the formation of new vessels.  
Deciphering the roles of specific proteolytic pathways has traditionally leveraged 
molecular genetic tools to create knock-out cells and animals (12, 56). However, redundancies in 
proteolytic enzyme expression and mechanisms of ECM degradation may complicate 
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interpretations from knock-outs. To complement such approaches, here we used engineered 
hydrogels (114) with selective degradability to investigate the relative importance of MMP- 
versus plasmin-dependent ECM degradation during capillary morphogenesis in 3D.  
4.3 MATERIALS AND METHODS 
4.3.1 Cell culture 
All reagents were obtained from Thermo Fisher Scientific (Waltham, MA) unless 
specified. Human umbilical vein endothelial cells (ECs) were harvested from fresh umbilical 
cords and cultured in fully supplemented EGM2 (Lonza, Walkersville, MD) as previously 
described (172). ECs were used between passages 2-4. Normal human dermal fibroblasts (DFs, 
Lonza) and normal human lung fibroblasts (LFs, Lonza) were cultured in Dulbecco’s modified 
eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin 
streptomycin and were used up to passage 15. Bone marrow mesenchymal stem cells (MSCs, 
RoosterBio, Frederick, MD) were cultured in RoosterNourish-MSC medium (RoosterBio) and 
used up to passage 5. All cells were cultured at 37 oC and 5% CO2 with thrice weekly medium 
exchange. These cell types were chosen because prior work has suggested they exhibit 
differential utilization of MMP- and plasmin-mediated proteolysis (7, 101). 
4.3.2 Fibrin-based vasculogenesis assay with drug inhibitors 
A 3D model of capillary morphogenesis was adapted from our previously described 
protocol (77) as follows. ECs (1.25x105 cells/mL) and a supportive stromal cell type (1.25x105 
cells/mL) were distributed in 0.5 mL fibrin hydrogels formed in a 24-well culture plate from 2.5 
mg/mL of 0.22 µm filtered bovine fibrinogen (Sigma-Aldrich, St Louis, MO) dissolved in serum 
free DMEM and polymerized with 1 U/mL bovine thrombin (Sigma). After gelation, 1 mL of 
Vasculife VEGF Endothelial Medium (Lifeline Cell Technology LLC, Frederick, MD) was 
60 
 
added to the hydrogel with indicated inhibitors. Aprotinin, derived from bovine lung (Sigma), 
was added in sterile water at a final concentration 2.2 µM, which is nearly 3 orders of magnitude 
greater than the IC50 for plasmin (4 nM) (207) and has been previously shown to have a 
saturating effect on capillary morphogenesis (62). The broad-spectrum MMP inhibitor, GM6001 
(Sigma), was supplemented in a constant volume of DMSO vehicle to achieve indicated 
concentrations.  
4.3.3 PEG-VS hydrogel formation 
Hydrogels were formed from 4-arm poly(ethylene glycol) vinyl sulfone (PEG-VS; 20 
kDa, Jenkem USA, Allen TX) and a combination of thiol containing adhesive and protease-
sensitive peptides adapted from published protocols (114, 127). All reagents were prepared in 
batches of single-use aliquots. Peptides, dissolved in 25 mM acetic acid, and PEG-VS, dissolved 
in ultrapure water, were 0.22 µm filtered, lyophilized, and stored desiccated at -20 oC. Precise 
thiol content of each batch of peptide aliquots was determined using Ellman’s reagent. An 
optimal thiol:vinyl sulfone ratio (typically 0.8-0.9) which yielded the maximum hydrogel shear 
modulus was also determined for each batch. Immediately before use, PEG-VS was dissolved in 
HEPES (100 mM, pH 8.4) and CGRGDS peptide (RGD, Genscript, Piscataway, NJ) was reacted 
with the PEG-VS for 30 min at a final concentration of 400 µM. In rapid succession, dithiol 
crosslinking peptides at the optimized thiol:vinyl sulfone ratio (accounting for RGD conjugation) 
were added to the PEG-VS solution, gently mixed, dispensed into a sterile 0.5 (for 30 μl gels) or 
1 mL (50 μl gels) syringe with the needle end cut off, and allowed to polymerize for 1 h at 37 oC 
in a sealed 50 mL conical tube. Crosslinking peptides included: Ac-
GCRDVPMS↓MRGGDRCG-NH2 (“VPMS”), Ac-GCYK↓NRDCG-NH2 (“YKNR”), Ac-
GCYK↓NRDVPMS↓MRGGDRCG-NH2 (“Dual”), and Ac-GCY(D-K)N(D-R)DCG-NH2 (“YD-
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KND-R”) each containing an N-terminal acetylation and a C-terminal amidation (Genscript, 
cleavage site indicated by ↓). Polymerized hydrogels were punched into culture medium or 
phosphate buffered saline (PBS).  
4.3.4 Mechanical and proteolytic characterization of PEG-VS hydrogels 
Hydrogels were allowed to swell overnight, then were mounted on an AR-G2 rheometer 
(TA Instruments, New Castle, DE) between an 8-mm measurement head and a Peltier stage, each 
covered with P800 sandpaper. Shear storage modulus (G’) was determined at 0.05 N normal 
force, 5% strain amplitude, and 1 Hz frequency and averaged over a 2-minute time sweep. For 
proteolysis experiments, hydrogels were allowed to swell overnight then transferred to either 5 
mU/mL plasmin from human plasma (Sigma) in PBS or to 1 U/mL collagenase IV from 
Clostridium histolyticum (used as a qualitative surrogate for MMP degradation as both MMPs 
and collagenase IV were found to degrade the VPMS peptide sequence) in PBS supplemented 
with 0.4 mM CaCl2 and 0.1 mM MgCl2. Shear modulus was measured at 0, 3, and 24 h. 30 µL 
hydrogels were used for proteolysis experiments. 50 µL hydrogels were used for all other 
experiments. 
4.3.5 PEG-based vasculogenesis assays 
Hydrogels were formed as above except that a cell pellet was resuspended just after 
adding the dithiol peptide to achieve a final cell density of 2x106 cells/mL of each cell type. 50 μl 
samples of the resulting suspension were dispensed into 1 mL syringes and polymerized as 
above. Each hydrogel was cultured in 2 mL of medium in a 12-well plate for 7 d. Either EGM2 
or Vasculife VEGF medium were used for these studies. Controls comparing results in both 
medium types were performed for selected conditions. For the drug inhibitor studies, medium 
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was exchanged daily and inhibitors were added as in the fibrin-based experiments. For all other 
experiments, medium was exchanged on days 1, 3, and 5.  
4.3.6 Fluorescent imaging and quantification methods 
On day 7, co-cultures were fixed with Z-fix (Anatech, Battle Creek, MI). All PEG-VS 
hydrogels were cut down the cylinder diameter prior to staining, yielding two halves. Samples 
were stained with rhodamine-conjugated lectin from Ulex europaeus (UEA, Vector Laboratories, 
Burlingame, CA, specific for endothelial cells, 1:200), 4’, 6-diamidino-2-phenylindol (DAPI, 1 
μg/ml, Sigma), and AlexaFluor 488 phalloidin (1:200). PEG-hydrogels were imaged on the cut 
side to ensure images were representative of cellular behavior within the hydrogels. Images were 
acquired using an Olympus IX81 microscope equipped with a disk scanning unit (DSU, 
Olympus America, Center Valley, PA) and Metamorph Premier software (Molecular Devices, 
Sunnyvale, CA). For all analyses, confocal z-stacks were acquired using the DSU. Z-series were 
collapsed into maximum intensity projections prior to analysis. Quantifications of vessel and 
nuclei densities were performed on 300 µm stacks (30 µm/slice) imaged at 4x. Total vessel 
length per region of interest (ROI) was quantified using the Angiogenesis Tube Formation 
module in Metamorph and reported as vessel length per volume of ROI (2.16 x 1.65 x 0.3 mm). 
Total nuclei per ROI was quantified using a custom ImageJ script (included in appendices). Cell 
body circularity and projected cell area per volume of ROI were quantified from 30 µm thick 
stacks (3 µm/slice) imaged at 10x with a custom ImageJ script (included in appendices). For 
each sample, 6 ROIs were used to determine a mean for each of 3 independent experiments.  
4.3.7 Statistics 
Statistical analysis was performed using GraphPAD Prism (La Jolla, CA). Unless noted, 
data are represented as mean ± standard deviation of at least 3 independent experiments. Data 
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were analyzed using one- or two-way ANOVA with Tukey post-hoc testing for pre-specified 
comparisons. A value of α < 0.05 was considered significant.  
4.4 RESULTS 
4.4.1 Synergistic restriction of vasculogenesis by broad spectrum inhibition of MMP- and 
serine protease-dependent pathways is stromal cell dependent. 
We first investigated how inhibition of MMP-dependent and plasmin-dependent 
fibrinolysis affected capillary morphogenesis in a model of vasculogenesis in which ECs were 
distributed with DFs, LFs, or MSCs for 7 d in fibrin hydrogels. The extent of baseline capillary 
morphogenesis depended on stromal cell identity, with the length of networks in EC-MSC co-
cultures 50% and 39% compared to EC-LF or EC-DF co-cultures respectively (Fig 4.1 and 
Supplemental, Fig 4.7). Baseline capillary morphogenesis was unaffected by vasculogenic 
medium used (Supplemental, Fig 4.8). GM6001, a broad-spectrum inhibitor of MMPs, 
consistently reduced vessel formation in a dose-dependent manner regardless of stromal cell 
identity (Fig 4.1 and Supplemental, Fig 4.7, p < 0.0001 by two-way ANOVA). Aprotinin, a 
broad-spectrum inhibitor of serine-proteases including plasmin, similarly tended to reduce vessel 
formation regardless of stromal cell identity (Fig 4.1, p < 0.05 by two-way ANOVA). The 
magnitude of the effect, however, was comparatively subtle for EC-MSC co-cultures (Fig 4.1D). 
In the absence of GM6001, aprotinin did not affect vessel density. However, the combination of 
aprotinin and GM6001 revealed a synergistic inhibitory effect from aprotinin that depended on 
GM6001 concentration for EC-DF and EC-LF co-cultures (two-way ANOVA interaction term p 
= 0.035 and 0.0009, respectively) but not MSCs (p = 0.46, Fig 4.1 and supplemental, Fig 4.7). 
In EC-LF and EC-DF co-cultures, concentrations of GM6001 that were orders of magnitude  
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greater than the nM IC50 range for most MMPs (208) were insufficient to fully inhibit capillary 
morphogenesis unless aprotinin also was present. Because inhibition of either protease system 
alone was insufficient to block capillary morphogenesis, these results support a model of partial  
proteolytic plasticity for vasculogenesis in EC-fibroblast co-cultures in fibrin. As a preliminary 
Figure 4.1:  Aprotinin acts synergistically with GM6001 to inhibit vasculogenesis in endothelial 
cell (EC) co-cultures with dermal fibroblasts (DFs) and lung fibroblasts (LFs) but not in co-
cultures with bone-marrow mesenchymal stem cells (MSCs) in 2.5 mg/mL fibrin hydrogels. 
Representative images of capillary-like networks formed in EC-DF co-cultures after 7 d with 
indicated inhibitor concentrations are shown stained with the endothelial-selective lectin from Ulex 
europaeus (UEA, red) to highlight networks (A). Scale bar = 500 µm. Multiple images at prespecified 
locations were acquired for each condition for co-cultures of ECs and DFs (B), LFs (C), or MSCs (D) 
for 3 independent experiments and network lengths were quantified per volume as outlined in the 
methods. Two-way ANOVA (GM6001, aprotinin, interaction) results: EC-DF (p < 0.0001, p = 
0.0218, p = 0.0349), EC-LF (p < 0.0001, p = 0.0059, p = 0.0009), EC-MSC (p < 0.0001, p = 0.0177, p 
= 0.459). 
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study to assess whether plasminogen delivered in culture media serum contributed to this 
synergistic restriction of capillary morphogenesis, we also quantified vessel formation in serum-
free media. Contrary to expectation, vessel formation in the presence of all 3 stromal cell types 
exhibited synergistic restriction of vessel formation with increasing concentrations of GM6001 
and inclusion of aprotinin (Supplemental, Fig 4.9). 
We also evaluated whether aprotinin and GM6001 induced changes in cell spreading and 
proliferation in serum containing cultures. The effects of protease inhibition on combined cell 
density (both EC and stromal cell) closely mirrored vessel density (Supplemental, Fig 4.10). 
Qualitatively, protease inhibition affected spreading of endothelial cells more than stromal cells. 
Aprotinin and maximal GM6001 severely attenuated, but did not completely block, spreading of 
any stromal cell type (Supplemental, Fig 4.11).  
4.4.2 Direct matrix degradation by plasmin is insufficient to support robust capillary 
morphogenesis. 
To investigate the hypothesis that fibroblasts induce both MMP- and plasmin-mediated 
matrix remodeling during capillary morphogenesis, we generated synthetic extracellular matrices 
using 4-arm PEG-VS crosslinked with peptides selectively degradable nearly exclusively by 
either MMPs or plasmin (Fig 2A) (114, 127). Hydrogels formed from PEG-VS crosslinked with 
YKNR were rapidly degraded by plasmin as assessed by loss of shear modulus over time, while 
equivalent hydrogels formed from either a negative control peptide synthesized with the D-
isomer of lysine and arginine (YD-KND-R) or VPMS were unaffected by plasmin after 24h (Fig 
4.2B). Inclusion of aprotinin at 2.2 µM prevented YKNR-hydrogel degradation by plasmin, 
resulting in gels with G’ values of 141 ± 10 Pa after 24 hours (p=0.42 compared to untreated 
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YKNR control). Taken together, these data show that plasmin exclusively degrades YKNR 
hydrogels.  
 Because DFs are readily available from skin and therefore may represent a viable cell 
source for engineered microvascular constructs, we primarily focused on this stromal cell type 
for further investigation in engineered PEG-VS hydrogel matrices with some comparison to LF 
supported cultures. When ECs and DFs were co-encapsulated within plasmin-sensitive YKNR 
hydrogels with formulations similar to our prior work (~40 mg/mL PEG-VS) (114), there was no 
Figure 4.2: Design of MMP- and plasmin-selective PEG-VS hydrogels. We designed PEG-VS 
hydrogel scaffold systems with selective protease sensitivity by crosslinking multiple-arm PEG-VS 
with dithiol peptides with selective sensitivity to plasmin or MMPs (A). Hydrogels were crosslinked, 
swollen in PBS overnight, exposed to plasmin (5 mU/mL), and at indicated times, characterized by 
shear rheology. Hydrogels crosslinked with YKNR were readily degradable by plasmin as measured 
by shear rheology, whereas VPMS and YD-KND-R crosslinked hydrogels were insensitive to plasmin 
Fig 2: Design of MMP- and plasmin-selective PEG-VS hydrogels. We designed PEG-VS hydrogel 
scaffold systems with selective protease sensitivity by crosslinking multiple-arm PEG-VS with dithiol 
peptides with selective sensitivity to plasmin or MMPs (A). Hydrogels were crosslinked, swollen in 
PBS overnight, exposed to plasmin (5 mU/mL), and at indicated times, characterized by shear 
rheology. Hydrogels crosslinked with YKNR were readily degradable by plasmin as measured by 
shear rheology, whereas VPMS and YD-KND-R crosslinked hydrogels were insensitive to plasmin (B). 
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clear evidence of capillary morphogenesis. By contrast, capillary-like structures were observed 
in MMP-sensitive VPMS hydrogels (Fig 4.3A and 4.3B). To investigate the possibility that  
vasculogenesis was limited by a grossly supraphysiologic number of matrix cleavage sites, we 
reduced the concentration of PEG-VS to generate hydrogels with decreasing crosslink density, as 
assessed by shear rheology, to the practical limits of gelation (G’ range for 27 mg/mL PEG-VS 
hydrogels 37 to 61 Pa, Fig 3C). This approach reduced the number of proteolysis events required 
for local hydrogel dissolution as well as diffusion restrictions. Hydrogel crosslinking, assessed 
Figure 4.3: Capillary morphogenesis is severely restricted in YKNR hydrogels regardless of 
crosslinking density. UEA (red) images from the centers of the constructs (see methods) are shown 
for loose (27 mg/mL PEG-VS) and dense (40 mg/mL) VPMS, YKNR, and YD-KND-R crosslinked 
hydrogels. Capillary-like networks formed in EC-DF co-cultures at all concentrations of PEG-VS 
when crosslinked with VPMS. In YKNR hydrogels, limited vessel formation was only observed in the 
softest (27 mg/mL) hydrogel formulation. No vessel formation was observed in non-degradable 
hydrogels (A). Scale bar: 500 µm. Vessel network length was quantified in each scaffold (*: p = 
0.0009 compared with YD-KND-R at fixed concentration, #: p = 0.008 compared with 27 mg/mL 
VPMS) (B). Peptide identity did not influence the shear modulus of hydrogels (two-way ANOVA: p = 
0.40) (C). 
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by shear rheology, did not depend on the crosslinking peptide identity (p= 0.30, Fig 4.3C). In  
loosely crosslinked YKNR hydrogels, we observed rare areas of minimal capillary 
morphogenesis (Fig 4.3A and 4.3B), but the formation of capillary-like structures was never as 
robust as observed in VPMS crosslinked hydrogels. Lack of vessel formation in 27 mg/mL 
YKNR hydrogels was also observed in LF supported cultures in a preliminary comparison to DF 
supported cultures (Supplemental, Fig 4.12). Quantified vessel density in 27 mg/mL YKNR 
hydrogels was similar to that seen in YD-KND-R controls (Fig 3B, p= 0.42). In VPMS hydrogels, 
vessel density was greater in 27 mg/mL compared with 40 mg/mL (Fig 3B, p = 0.008). Capillary 
Figure 4.4: Reduced crosslinking density allows for fibroblast spreading in YKNR crosslinked 
PEG-VS hydrogels. ECs and DFs were encapsulated in PEG-VS hydrogels with varying peptide 
identity and crosslinking density, controlled by initial PEG-VS concentration. UEA (red), phalloidin 
(green), and DAPI (blue) co-stained images from the centers of the constructs are shown for loose (27 
mg/mL PEG-VS) and dense (40 mg/mL) VPMS, YKNR, and YD-KND-R crosslinked hydrogels (A). 
Fibroblasts are phalloidin positive but UEA negative. Scale bar: 100 µm. Circularity was quantified 
(see methods) as a measure of cell spreading in loose (27 mg/mL PEG-VS), intermediate (32 mg/mL), 
and dense (40 mg/mL) crosslinked hydrogels (*: p ≤ 0.003 for comparison shown) (B). 
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morphogenesis in VPMS hydrogels did not depend on the vasculogenic medium used 
(Supplemental, Fig 4.13).  
To confirm that cell-mediated degradation is possible in plasmin-selective hydrogels, we 
examined cell spreading in EC-dermal fibroblast co-cultures (Fig 4.4A) and quantified cell  
circularity as a measure of cell spreading (Fig 4.4B). Circularity discriminates rounded versus 
spread cells (values of 1 indicate perfectly round cells, lower circularity indicates increased 
elongation). Circularity was low for a large fraction of cells in all VPMS and loosely-crosslinked 
YKNR hydrogels but was near 1 for most cells in 40 mg/mL YKNR hydrogels (Fig 4.4B). The 
lack of spreading in any YD-KND-R hydrogels indicated cell spreading depended on matrix 
degradation (Fig 4.4B). Qualitatively, we noted cell spreading in YKNR hydrogels 
predominantly occurred in UEA negative fibroblasts (Fig 4.4A), suggesting EC spreading was 
disproportionately restricted in plasmin-selective hydrogels.  
4.4.3 Hydrogels with dual susceptibility to both plasmin and MMPs do not enhance 
vasculogenesis compared with MMP-selective hydrogels.  
Our results to this point suggested that plasmin-mediated matrix remodeling was not 
sufficient to support capillary morphogenesis but did not rule out the possibility that plasmin 
may have an auxiliary role, perhaps partially degrading the matrix ahead of vessel invasion to 
facilitate localized MMP mediated degradation. To assess this possibility, we generated a 
synthetic ECM in which each crosslink could be degraded either by MMPs or by plasmin using a 
concatenated YKNR+VPMS dual susceptible peptide (Fig 4.5A). Hydrogels crosslinked with the 
dual susceptible peptide were degradable by both plasmin and collagenase (used as a surrogate  
for MMP-mediated degradation) (Fig 4.5B) and had shear moduli similar to VPMS controls (Fig 
4.5C). EC-DF cocultures in dual susceptible hydrogels resulted in vessel density, projected cell 
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area, and nuclei density equivalent to gels crosslinked with the VPMS peptide (Fig 4.5D, 4.5E, 
4.5F). Similarly, EC-LF cocultures did not exhibit any differences in vessel formation or nuclei  
densities between hydrogels crosslinked with either VPMS or dual susceptible peptides 
(Supplemental, Fig 4.14A, 4.14B) 
4.4.4 Synergistic restriction of vasculogenesis by broad spectrum inhibition of MMP- and 
serine protease-dependent pathways is abolished in MMP-sensitive hydrogels.  
Figure 4.5: Hydrogels with crosslinks sensitive to either plasmin or MMPs did not enhance 
capillary morphogenesis. PEG-VS hydrogels were crosslinked with a concatenated peptide 
containing both VPMS and YKNR sequences and used to form scaffolds in which each crosslink was 
susceptible to either MMPs or plasmin (A). Dense PEG-VS hydrogels were crosslinked with the dual 
susceptible peptide, swollen in PBS overnight, exposed to indicated proteases, and at indicated times, 
characterized by shear rheology (B). EC-DF co-cultures were generated in intermediate-crosslinked 
(32 mg/mL PEG-VS) scaffolds crosslinked with either VPMS or dual-susceptible peptides (C-F). 
Network structure of these scaffolds, assessed by shear rheology, did not depend on crosslinking 
peptide (p = 0.36) (C). Vessel density, quantified after 7 d, was similar for VPMS and dual susceptible 
peptides (p = 0.65) (D). Cell spreading was estimated by projected cell area per volume and did not 
differ for VPMS and dual susceptible peptides (p = 0.11) (E). There were no differences in cell 
density after 7 d, measured by automated counting of DAPI stained nuclei per volume (p = 0.63) (F). 
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Since plasmin can activate soluble MMPs, including those involved in capillary 
morphogenesis (5), another potential explanation for the reduced vasculogenesis in fibrin 
cultures containing aprotinin may be inhibition of plasmin-dependent activation of MMPs. To 
investigate this possibility, inhibition experiments similar to those shown in Fig 1 were repeated 
in VPMS crosslinked PEG-VS hydrogels that could only be degraded by MMPs. Similar to 
results in fibrin, GM6001 reduced vessel formation in a dose dependent manner (Fig 4.6, two-
way ANOVA p = 0.0003). However, unlike in fibrin, we observed no meaningful differences in 
vasculogenesis when aprotinin was added to cultures containing GM6001 (Fig 4.6, two-way 
ANOVA, aprotinin effect p = 0.21, interaction p = 0.75). Similarly, no synergistic effect was 
observed in EC-LF co-cultures (Supplemental, Fig 4.15).  
4.5 DISCUSSION 
The goal of these studies was to implement a biomaterial engineering approach to 
investigate the relative importance of plasmin- and MMP-mediated matrix degradation in 
capillary morphogenesis. Our previous work has suggested that the identity of stromal cells used 
to support capillary morphogenesis influences the relative importance of MMP- and plasmin-
Figure 4.6: Cooperative GM6001 and aprotinin inhibition is abolished in VPMS crosslinked 
hydrogels. EC-DF co-cultures were generated in intermediate-crosslinked (32 mg/mL PEG-VS) 
hydrogels and cultured for 7 d in the presence of protease inhibitors GM6001 (concentration shown) 
or aprotinin (2.2 µM). Representative images stained with UEA (red) under indicated conditions are 
shown (A). Scale bar: 500 µm. Vessel density was quantified for each condition (B). Two-way 
ANOVA (GM6001, aprotinin, interaction) results: (p < 0.0003, p = 0.21, p = 0.75). 
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dependent matrix remodeling in fibrin (7, 101). These differences correlate with vessel function 
(7, 10, 11). Therefore, determining the relative roles of plasmin and MMPs in capillary 
morphogenesis may have critical implications for neovessel function and in the design of 
biomaterial scaffolds to support vascularization.  
First, we investigated whether stromal-cell-dependent differences in the mechanism of 
proteolysis in fibrin hydrogels observed in angiogenesis models (7, 101) extended to a model of 
vasculogenesis. This model mimics vascularization strategies often deployed for tissue 
engineering applications that involve injection of populations of cells (11, 114) or pre-patterned 
cell aggregates (118, 209) that organize into microvasculature. The phenotype and angiogenic 
potential of microvascular ECs (98, 210) and stromal cells (7, 10, 11, 101, 211) vary widely 
according to their origin. We chose umbilical vein-derived ECs and supporting cells derived 
from bone marrow, lung, and dermis to explore in our model because our prior work has 
suggested differential utilization of MMP- and plasmin-mediated proteolysis with these 
combinations (7, 101). Furthermore, this EC source has been utilized widely for understanding 
mechanisms of capillary morphogenesis (212). Though we did not specifically test ECs from 
other origins, an essential role for MMPs in capillary morphogenesis has been described for 
microvascular (12, 213), macrovascular (7, 12), and stem cell-derived (98) ECs as has a role for 
plasmin with ECs derived from both macrovascular (7) and microvascular sources (58–61). As a 
result, we anticipate that programs of proteolytic remodeling implied by our investigation are 
likely generalizable to endothelium from a variety of origins.  
For EC-fibroblast co-cultures in this model, we observed 1) a synergistic inhibition of 
capillary morphogenesis between aprotinin and high concentrations of GM6001 (≥ 10 μM) and 
2) robust inhibition required both inhibitors. In contrast, GM6001 alone was sufficient to block 
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capillary morphogenesis in EC-MSC co-cultures. These results suggest that fibroblasts can 
induce a program of capillary morphogenesis that utilizes both MMP- and plasmin-dependent 
mechanisms of matrix remodeling consistent with our prior observations (7, 101). The observed 
IC50 for GM6001 for capillary morphogenesis, regardless of stromal cell identity, was 
approximately 1 µM. This level is at least two orders of magnitude greater than the IC50 for 
most MMPs (208), suggesting that inhibition of capillary morphogenesis, and thus any evidence 
of escape from MMP inhibition due to pericellular plasmin activity, does not occur until MMP 
activity is fully abolished. While it is possible the observed aprotinin-GM6001 synergy 
represents off-target effects from the single inhibitor used for each enzyme class in these studies, 
the fact that similar findings have been observed with a wide range of inhibitors for both MMPs 
and plasmin pathways in similar models (7, 55, 98, 101) suggests this explanation is unlikely. 
Together, these results suggest that plasmin can act as a pericellular protease only in 
circumstances in which the preferred MMP-dependent pathway is essentially inactivated, 
highlighting the essential role MMPs play.  
To investigate the role of plasmin further, we designed synthetic PEG hydrogel ECMs 
(114, 127) in which matrix degradation was selectively limited to MMP- or plasmin-mediated 
mechanisms by crosslinking the scaffold with protease-selective peptides. We selected the 
peptide sequences VPMSMRGG (denoted VPMS), which can be degraded by a variety of MMPs 
(MT1-MMP and MMPs 1, 2, 3, 7, and 9) (214), support cell invasion (130), and support 
capillary morphogenesis (114) and YKNR, which is plasmin-sensitive and previously optimized 
for Michael addition reactions (132). Although this approach provides a selectively degradable 
ECM model, PEG-VS hydrogels lack many of the pro-angiogenic properties of fibrin, which 
include a fibrous architecture, macro-porous features, binding sites for multiple cell adhesion 
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molecules other than RGD, and binding sites for a variety of growth factors (215). Also, cells 
encapsulated in PEG-VS were never exposed to thrombin, which can activate endothelial cells, 
though the short duration of exposure in our study (30 min) leads to minimal EC activation (216) 
and is unlikely to have a meaningful impact over a 7 d culture period. Furthermore, soluble 
proteases may play an important role in cell-mediated degradation and migration in peptide 
crosslinked PEG-based hydrogels (217, 218). This property may restrict capillary 
morphogenesis, which requires membrane bound MT1-MMP in natural ECMs (12). Despite 
these limitations, capillary morphogenesis occurred in all VPMS-crosslinked hydrogels. 
However, a higher initial cell density was needed (targeted at the typical final cell density 
observed in fibrin gels) and the resulting capillary-like networks were never as extensive as in 
fibrin. 
Initially, in formulations similar to our previous work (40 mg/mL) (114), we observed 
that spreading of both ECs and stromal cells was severely restricted in YKNR-crosslinked 
hydrogels. This observation is potentially explained by the fact that PEG-VS hydrogels have a 
nanoscale architecture with a mesh size on the order of 10-100 nm, in contrast to micron-scale 
pores in fibrin (219). As a result, the number of pericellular crosslinks that require degradation to 
permit cell spreading is at least 400 times greater in 40 mg/mL PEG-VS hydrogels compared 
with 2.5 mg/mL fibrin (estimated using the starting concentrations of each material, with 2 
degradation events per PEG-VS molecule and 1 degradation event per fibrin molecule (220) 
needed for network dissolution). We also previously observed significant diffusion restrictions in 
these hydrogels for larger molecular weight molecules similar in size to plasminogen (114), 
which is supplied by serum and fibrinogen impurities in our vasculogenic culture system and is a 
necessary precursor to plasmin-mediated proteolysis.  
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To overcome these limitations, we generated PEG-VS matrices near the limits of gelation 
to reduce the number of pericellular crosslinks and minimize diffusion restrictions. In these 
loosely crosslinked YKNR hydrogels, we observed invasion of the surrounding matrix by 
fibroblasts. A persistent lack of spreading in control plasmin-insensitive YD-KND-R hydrogels 
confirmed cell spreading depended on degradation of the YKNR peptide. These observations 
indicated that limitations in vasculogenesis could be attributed to differences in the proteolytic 
preferences of endothelial cells rather than gross limitations in matrix degradability or 
plasminogen diffusion. This observation that plasmin-mediated degradation requires the PEG-VS 
hydrogel scaffold to be near the gelation point also may explain conflicting reports regarding the 
ability of fibroblasts to degrade YKNR crosslinked PEG hydrogels (132, 219). However, only in 
very loosely crosslinked YKNR hydrogels did we begin to observe occasional rudimentary 
vasculogenesis, which was never seen in similar soft control YD-KND-R hydrogels. In contrast, 
very soft control hydrogels crosslinked with VPMS tended to support more robust network 
formation, suggesting a correlation between MMP-degradability and vasculogenesis that 
highlights the dominant role of MMPs in capillary morphogenesis. 
These findings are also consistent with other studies noting that increasing crosslink 
degradability (91) or a more loosely crosslinked network structure (221) correlate with increased 
capillary morphogenesis. Furthermore, in adipocyte-derived stem cell-EC cocultures, others have 
observed evidence that plasmin-mediated ECM degradation becomes increasingly important in 
densely crosslinked fibrin(62). Consequently, we hypothesized that plasmin may partially 
degrade the fibrin network rendering it more susceptible to MMPs and thus facilitating 
vasculogenesis. To evaluate this hypothesis, we generated PEG hydrogels where each crosslink 
was susceptible to either MMPs or plasmin by merging both the VPMS and YKNR peptides 
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sequences. These hydrogels were indistinguishable from VPMS-crosslinked controls, both in 
initial physical properties and in their ability to support capillary morphogenesis. These findings 
suggested that partial ECM-degradation by plasmin did not contribute significantly to capillary 
morphogenesis and that the kinetics of ECM remodeling were dominated by MMPs in our PEG-
hydrogel co-culture system.  
A possible explanation of the apparent role of plasmin-dependent pathways in fibrin 
hydrogels (based on inhibitor studies) but the failure of capillary morphogenesis in selectively 
plasmin-sensitive ECMs is that plasmin’s role does not involve direct matrix degradation. 
Plasmin is a potent activator of MMP-3, which in turn activates MMP-9 to increase cellular 
invasiveness (222). If indirect plasmin-mediated activation of MMPs contributed to 
vasculogenesis, then we hypothesized that we should observe a synergy between aprotinin and 
GM6001 not only in fibrin but also in VPMS hydrogels. Moreover, the VPMS peptide is 8-times 
more sensitive to cleavage by MMP-9 than MT1-MMP (214), which is of critical importance in 
vessel formation (7, 55), making VPMS hydrogels an ideal environment to test this hypothesis. 
However, our experiments demonstrated no synergy between GM6001 and aprotinin in VPMS 
PEG-VS hydrogels, again highlighting the importance of MMPs alone.  
There are several other possible explanations for the observed GM6001-aprotinin inhibition 
synergy in fibrin which we did not investigate further. Plasmin binding to αvβ3 on endothelial 
cells has been shown to induce endothelial migration (63), offering a potential alternative 
mechanism by which it may stimulate angiogenesis. Aprotinin also inhibits other serine 
proteases. Kallikrein, which is synthesized and secreted by ECs and cleaves kininogens into pro-
angiogenic kinins (223), may also be present and inhibited at the concentration of aprotinin 
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utilized here (IC50 1-100 nM) (224) to reduce capillary morphogenesis under conditions of 
MMP inhibition.   
Taken together, these results emphasize the utility of engineered ECM mimetics to better 
understand the mechanisms by which the ECM regulates complex morphogenetic programs in 
3D. In particular, our results underscore the essential role for MMP-mediated ECM degradation 
during capillary morphogenesis and generalize the findings of prior studies in fibrin and collagen 
hydrogels (7, 12, 55, 56) to a precisely defined synthetic ECM. In contrast, our findings do not 
support a role for plasmin-mediated matrix remodeling in capillary morphogenesis, but instead 
suggest plasmin may contribute only under very limited circumstances (e.g. in fibrin with near 
complete MMP inhibition or in situations of supraphysiologic fibrin concentration (62)); such 
circumstances are unlikely to be physiologically significant. Our model also provides a tool to 
investigate matrix remodeling in organotypic capillary morphogenesis with specific EC and 
stromal cell combinations. Finally, the unique matrix-centric perspective of these studies 
provides strong evidence to justify the preferential selection of MMP-degradable peptide 
crosslinkers in synthetic hydrogels used to study vascular morphogenesis (69, 89, 91, 106, 221, 
225–227) and promote vascularization. 
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4.6 SUPPLEMENTAL FIGURES 
 
 
 
Figure 4.7:  Representative images of capillary-like networks formed in EC-LF (A) or EC-MSC (B) 
co-cultures in 2.5 mg/mL fibrin at 7 d. Inhibitor concentrations are indicated, endothelial cells are 
shown stained with UEA (red) to highlight networks. Scale bar = 500 microns. 
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Figure 4.8:  Vasculogenesis in fibrin hydrogels is equivalent in Vasculife VEGF (VL) and EGM-2 
and is not affected by DMSO vehicle. Both types of vasculogenic culture medium were used for 
experiments (see methods). Shown are quantified network lengths for EC co-cultures with DFs (A), LFs 
(B), and MSCs (C) in 2.5 mg/mL fibrin after 7 d in culture. Vasculife medium with DMSO, with and 
without aprotinin, is replicated from Fig 1 for comparison. DMEM only, a non-vasculogenic medium, 
was used as a negative control for vasculogenesis.  
 
 
Figure 4.9: In serum free culture media, aprotinin acts synergistically with GM6001 to inhibit 
vasculogenesis in endothelial cell (EC) co-cultures with dermal fibroblasts (DFs), lung fibroblasts 
(LFs) and bone-marrow mesenchymal stem cells (MSCs) in 2.5 mg/mL fibrin hydrogels. Multiple 
images at prespecified locations were acquired for each condition for co-cultures of ECs and DFs (A), 
LFs (B), or MSCs (C) for 3 independent experiments and network lengths were quantified per volume as 
outlined in the methods. In 2 of 3 experiments, 3D fibrin constructs formed from lung fibroblasts 
completely degraded during the culture precluding quantification of vessel density but inclusion of 
aprotinin stabilized the constructs in all cases (B). *: p < 0.05 for specified conditions. 
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Figure 4.10:  GM6001 cooperates with aprotinin to inhibit cell proliferation in a similar 
fashion as capillary morphogenesis. Multiple DAPI stained images at prespecified locations 
were acquired for each condition for co-cultures of ECs with DFs (A), LFs (B), and MSCs (C) 
for 3 independent experiments and the density of nuclei (as a measure of cell density) was 
quantified as outlined in the methods. Dotted line represents baseline nuclear density measured 
the day after seeding.  Two-way ANOVA (GM6001, aprotinin, interaction) results: EC-DF (p < 
0.0001, p = 0.0301, p = 0.3718), EC-LF (p < 0.0001, p = 0.0405, p = 0.0003), EC-MSC (p < 
0.0001, p = 0.0461, p = 0.1351). 
 
 
 
Figure 4.11: Dual inhibition with GM6001 and aprotinin severely attenuates, but never 
fully abolishes, stromal cell spreading in fibrin. Representative areas of EC co-cultures with 
DFs, LFs, and MSCs in 2.5 mg/mL fibrin are shown fixed at 7 d and stained with UEA (red), 
phalloidin (green) and DAPI (blue) with indicated inhibitors added. Stromal cells are phalloidin 
positive but UEA negative. Scale bars: 100 µm.  
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Figure 4.12: Capillary morphogenesis is equally restricted in 27 mg/mL YKNR hydrogels for EC-
LF and EC-DF cocultures. Vessel network length was quantified on day 7 in each scaffold as defined in 
the methods. Results from 2 replicates and their mean value are shown from matched cultures of EC-DF 
and EC-LF in which EC pellets and hydrogel formulations were identical. 
 
 
Fig 4.13: Capillary morphogenesis in VPMS-PEG-VS hydrogels did not depend on 
vasculogenic medium used. Vessel density was quantified in PEG-VS scaffolds with the 
indicated composition crosslinked with VPMS peptide then cultured for 7 d in either EGM-2 or 
Vasculife VEGF (VL) medium. No significant differences (N = 3) were noted comparing each 
medium in the same hydrogel composition (ANOVA media effect: p = 0.23, Tukey post hoc 
analysis for 40 mg/ml PEG-VS EGM-2 vs. VL: p = 0.73). We noted increased capillary 
morphogenesis in 27 mg/ml PEG-VS hydrogels compared with 40 mg/ml hydrogels regardless 
of medium used (Tukey post hoc analysis for 27 vs 40 mg/mL PEG-VS in the same medium: p < 
0.036). 
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Fig 4.14 EC-LF cocultures demonstrate similar behavior as EC-DF cocultures with no 
enhancement of capillary morphogenesis in dual sensitive hydrogels. PEG-VS hydrogels were 
crosslinked with a concatenated peptide containing both VPMS and YKNR sequences and used to form 
scaffolds in which each crosslink was susceptible to either MMPs or plasmin. EC-LF co-cultures were 
generated in intermediate-crosslinked (32 mg/mL PEG-VS) scaffolds crosslinked with either VPMS or 
dual-susceptible peptides. Vessel density, quantified after 7 d, was similar for VPMS and dual susceptible 
peptides (A). There were no differences in cell density on d1 or after 7 d, measured by automated 
counting of DAPI stained nuclei per volume (B).  
 
Figure 4.15: EC-LF cocultures do not exhibit cooperative GM6001 and aprotinin inhibition in 
VPMS crosslinked hydrogels. EC-LF co-cultures were generated in intermediate-crosslinked (32 
mg/mL PEG-VS) hydrogels and cultured for 7 d in the presence of protease inhibitors GM6001 
(concentration shown) or aprotinin (2.2 µM). Vessel density was quantified for each condition.Two-way 
ANOVA (GM6001, aprotinin, interaction) results: (p < 0.0001, p = 0.081, p = 0.855). 
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CHAPTER V 
Enhanced Proteolytic Susceptibility Of Matrix Metalloproteinase-Selective Poly(Ethylene 
Glycol) Hydrogels Increases Capillary Network Formation. 
 
5.1 ABSTRACT 
Matrix metalloproteinase-mediated extracellular matrix (ECM) remodeling is essential 
for capillary morphogenesis. Here we employed poly(ethylene glycol) (PEG) based hydrogels 
engineered with varying MMP-mediated proteolytic susceptibility to investigate the effect of 
hydrogel degradability on capillary self-assembly in a 3D cell culture model analogous to 
vasculogenesis. We first demonstrated that incorporating a double repeat of the protease 
recognition sequence in the hydrogel crosslinker resulted in enhanced proteolytic susceptibility 
without affecting initial hydrogel mechanical properties. We then demonstrated that enhanced 
proteolytic susceptibility resulted in increased capillary network density after 8 days in culture 
but was not associated with a significant difference in total nuclei density depending on crosslink 
identity. Both hydrogel formulations exhibited hydrogel stiffening during culture, with a higher 
degree of stiffening associated with enhanced proteolytic susceptibility. A preliminary study of 
hydrogels implanted subcutaneously suggested that enhanced proteolytic susceptibility may also 
facilitate morphogenesis in vivo but is severely restricted compared to in vitro culture. 
Histological sectioning suggested minimal host infiltration in acellular hydrogels, and possible 
fibrous capsule formation at the hydrogel-tissue interface. These findings contribute to a 
fundamental understanding of the effect of proteolytic remodeling on capillary morphogenesis in 
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PEG hydrogels, and provide a convenient means of enhancing capillary morphogenesis in tissue 
engineering applications that require rapid tissue construct vascularization. 
5.2 INTRODUCTION 
Systematically characterizing the influence of synthetic scaffold properties on cellular 
phenotypic responses helps provide insights into factors that regulate capillary morphogenesis 
and techniques for improving vascularization of tissue constructs. This chapter specifically 
investigates how the susceptibility of poly(ethylene glycol) (PEG)-based hydrogels to matrix-
metalloproteinase (MMP)-mediated proteolysis affects the rate at which vessels self-assemble. 
Increasing extracellular matrix density in tissue constructs effectively results in decreased 
degradability and typically correlates with decreased vessel formation in natural (176, 196, 228), 
semi-synthetic (202, 229, 230), and synthetic hydrogels (91, 114, 133, 221). Moreover, MMP 
inhibition is known to inhibit capillary morphogenesis in a dose dependent manner in both 
natural and synthetic hydrogels (7, 231). Together, these studies suggest proteolytic activity and 
matrix degradability are key regulators of vessel invasiveness. Changing the concentration of 
ECM, however, results in concomitant changes in diffusive transport (114, 176), matrix stiffness 
(64), and ligand presentation (196) and inhibitor studies may have off target effects. These 
numerous convolutions make PEG-based hydrogels appealing because the rate of degradation 
can be altered by changing the crosslink identity without affecting other matrix properties.  
We have previously assessed the effect of  proteolytic selectivity on capillary self-
assembly in PEG hydrogels (12), but we have not directly addressed whether modulating PEG-
hydrogel degradability to MMPs affects vessel formation. Other groups have demonstrated that 
matrix degradability affects the rate of cellular invasion (91) as well as the multicellularity of EC 
invasion (89) in synthetic hydrogels, but the effect of matrix degradability on vessel formation in 
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a vasculogenic model of capillary self-assembly has not been investigated. We compared 2 
distinct proteolytically degradable crosslinkers; a commonly used MMP-sensitive crosslinker 
termed “VPMS” (114, 123, 130, 231) and a double repeat of the protease recognition sequence to 
enhance hydrogel degradability. Although this changes the crosslink length, it is negligible 
compared to the length of the arms of the PEG molecules. Including multiple repeats of the 
protease recognition sequence in the peptide crosslinker in a similar hydrogel system has 
previously been shown to increase proteolytic degradability without affecting hydrogel swelling, 
mesh size, or compressive modulus (91). In addition to quantifying differences in vessel 
formation depending on crosslink identity, cellular proliferation and change in hydrogel 
mechanics over time was also quantified. Furthermore, morphogenetic behavior in vitro was 
compared to an in vivo subcutaneous implant model.  
5.3 MATERIALS AND METHODS 
5.3.1 Cell culture 
Human umbilical vein endothelial cells (ECs) were harvested from fresh umbilical cords 
and cultured in fully supplemented EGM2 (Lonza, Walkersville, MD) as previously described 
(172)15. ECs were used between passages 2-4. Normal human dermal fibroblasts (DFs, Lonza) 
were cultured in Dulbecco’s modified eagle medium (DMEM) supplemented with 10% fetal 
bovine serum (FBS) and 1% penicillin streptomycin and were used up to passage 15. Both cell 
types were cultured at 37 oC and 5% CO2 with thrice weekly medium exchange.  
5.3.2 PEG-VS hydrogel formation 
Hydrogels were formed from 4-arm poly(ethylene glycol) vinyl sulfone (PEG-VS; 20 
kDa, Jenkem USA, Allen TX) and a combination of thiol containing adhesive and protease-
sensitive peptides adapted from published protocols (114, 127)14,19. All reagents were prepared in 
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batches of single-use aliquots.  To minimize variability between experiments, all hydrogels 
presented within this chapter were formed from identical aliquots from single batches of PEG-
VS and peptides. Peptides, dissolved in 25 mM acetic acid, and PEG-VS, dissolved in ultrapure 
water, were 0.22 µm filtered, lyophilized, and stored desiccated at -20 oC. Precise thiol content 
of each batch of peptide aliquots was determined using Ellman’s reagent. An optimal thiol:vinyl 
sulfone ratio which yielded a hydrogel shear modulus of 200 Pa for acellular hydrogels was 
determined for each crosslinking peptide. Immediately before use, PEG-VS was dissolved in 
HEPES (100 mM, pH 8.4) to achieve a final concentration in formed hydrogels of 30 mg/ml 
PEG-VS and CGRGDS peptide (RGD, Genscript, Piscataway, NJ) was reacted with the PEG-VS 
for 30 min to acheive a final concentration of 500 µM. In rapid succession, dithiol crosslinking 
peptides at the optimized thiol:vinyl sulfone ratio (accounting for RGD conjugation) were added 
to the PEG-VS solution, gently mixed, and 50 μl of precursor solution was dispensed into a 
sterile 1 mL syringe with the needle end cut off, and allowed to polymerize for 1 h at 37 oC in a 
sealed 50 mL conical tube.  
Crosslinking peptides included: Ac-GCRDVPMS↓MRGGDRCG-NH2 (“VPMS”) and 
Ac-GCRDVPMS↓MRGGVPMS↓MRGGDRCG-NH2 (“2xVPMS”) each containing an N-
terminal acetylation and a C-terminal amidation (Genscript, cleavage sites indicated by ↓). 
Polymerized hydrogels were punched into culture medium or phosphate buffered saline (PBS).  
5.3.3 Mechanical and proteolytic characterization of PEG-VS hydrogels 
Hydrogels were allowed to swell overnight, then were mounted on an AR-G2 rheometer 
(TA Instruments, New Castle, DE) between an 8-mm measurement head and a Peltier stage, each 
covered with P800 sandpaper. Shear storage modulus (G’) was determined at 0.05 N normal 
force, 5% strain amplitude, and 1 Hz frequency and averaged over a 1-minute time sweep. For 
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proteolysis experiments, hydrogels were allowed to swell overnight then transferred to 1 U/mL 
collagenase IV from Clostridium histolyticum (used as a qualitative surrogate for MMP 
degradation as both MMPs and collagenase IV can degrade the VPMS peptide sequence) in PBS 
supplemented with 0.4 mM CaCl2 and 0.1 mM MgCl2. The shear modulus of hydrogels were 
measured at 0, 1.5, and 3 h to determine differences in degradation depending on crosslinking 
peptide.  
5.3.4 In vitro vasculogenesis assay 
Hydrogels were formed as above except that a cell pellet was resuspended in the 
crosslinking peptide precursor solution immediately before mixing with PEG-VS solution to 
achieve a final cell density of 5x106 cells/mL of each cell type. VPMS and 2xVPMS replicates 
were paired to receive identical cell pellets.50 μl samples of the resulting suspension was then 
dispensed into 1 mL syringes and polymerized as above for 1 hour. Hydrogels were then 
punched out into 2 mL of Vasculife VEGF medium in a 24-well plate. Media was exchanged on 
day 1 then on alternate days thereafter for 8 days. At the end of the experiment, in vitro hydrogel 
co-cultures were fixed with Z-fix (Anatech, Battle Creek, MI) for 1 hr, rinsed 4x in PBS, and 
then stored at 4 °C. 
5.3.5 In vivo subcutaneous implant model 
All animal procedures were performed in accordance with the National Institutes of 
Health (NIH) guidelines for laboratory animal usage and approved by the University of 
Michigan’s, Institutional Animal Care and Use Committee. Male CB17/SCID mice (6–8 weeks 
old; Taconic Labs, Hudson, NY) were used for all experiments. Mice were anesthetized in an 
induction chamber with 5% isoflurane at 1 L/min O2 (Cryogenic Gases, Detroit, MI) using a V‐1 
Tabletop isoflurane vaporizer system equipped with an Active Scavenging Unit (VetEquipt, 
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Livermore, CA). Once mice were fully anesthetized, they were moved to the surgical bench and 
fitted with an active scavenging nose cone with the isoflurane level reduced to 1%. Carprofen 
(5mg/kg) was administered to each animal prior to surgery and 24 hrs post-surgery via 
subcutaneous injection. The dorsal flanks of each mouse were shaved and depilatory agent (Nair; 
Thermo Fisher Scientific, Pittsburg, PA) was applied to remove any remaining hair. The surgical 
site was then sterilized with three alternating applications of ethanol and betadine (Thermo 
Fisher Scientific, Fremont, CA).  
Once animals were prepared for surgery, hydrogels to be implanted were retrieved from 
the incubator. Implanted hydrogels were paired with identical hydrogels cultured in in vitro 
assays for direct comparison of morphogenetic behavior. Each mouse received 2 implants: paired 
2xVPMS and VPMS hydrogels with identical cell pellets. Hydrogels were implanted intact after 
1 day in Vasculife VEGF medium. Two incisions were made on either side of the dorsal flank 
approximately 1 cm wide and a subcutaneous pocket approximately 2 cm deep was created. The 
hydrogel was then inserted into the subcutaneous pocket while being careful not to trap any air. 
The surgical incision was then closed with non-absorbable sutures. Animals were euthanized on 
day 7 (8 days after hydrogel formation) by CO2 overdose and hydrogels were retrieved via gross 
dissection with adherent adjacent skin and muscle layers intact. Hydrogels were immediately 
fixed for 4 hours in Z-fix, and then moved to a 10x dilution of Z-fix in PBS overnight at 4 °C. 
Samples were then washed 4x in PBS and stored in 70% ethanol at 4 °C.  
5.3.6 Fluorescent imaging and quantification methods 
Imaging and analysis of in vitro hydrogels and whole-mount imaged ex vivo samples 
were performed identically. All PEG-VS hydrogels were cut down the cylinder diameter prior to 
staining, yielding two halves. Samples were stained with rhodamine-conjugated lectin from Ulex 
89 
 
europaeus (UEA, Vector Laboratories, Burlingame, CA, specific for endothelial cells, 1:200), 4’, 
6-diamidino-2-phenylindol (DAPI, 1 μg/ml, Sigma), and AlexaFluor 488 phalloidin (1:200). 
PEG-hydrogels were imaged on the cut side to ensure images were representative of cellular 
behavior within the hydrogels. Images were acquired using an Olympus IX81 microscope 
equipped with a disk scanning unit (DSU, Olympus America, Center Valley, PA) and 
Metamorph Premier software (Molecular Devices, Sunnyvale, CA). For all analyses, confocal z-
stacks were acquired using the DSU. Z-series were collapsed into maximum intensity projections 
prior to analysis. Quantifications of vessel and nuclei densities were performed on 200 µm stacks 
(50 µm/slice) imaged at 4x. Total vessel length per region of interest (ROI) was quantified using 
the Angiogenesis Tube Formation module in Metamorph and reported as vessel length per 
volume of ROI (2.16 x 1.65 x 0.3 mm). Total nuclei per ROI was quantified using a custom 
ImageJ script (included in appendix).  
5.3.7 Histological sectioning and staining 
Excess tissue was removed from implants, and samples were placed in embedding 
cassettes (UNISETTE cassette with lid; Simport, Beloeli, QC, Canada), dehydrated, and 
embedded in paraffin using a KD‐BMII tissue embedding center (IHCWorld, Ellicott City, MD). 
Samples were oriented such that the cutaneous layer would be sectioned first. Sections 10 μm 
thick of embedded samples were then generated with a Thermo Fisher Scientific HM 325 rotary 
microtome and placed on glass slides. Paraffin sections on glass slides were dewaxed in xylene 
baths twice for 5 min and then washed in progressively decreasing concentrations of ethanol 
solution. Slides were then rehydrated in deionized water and stained with Mayer’s hematoxylin 
(Electron Microscopy Sciences, Hatfield, PA) and Eosin Y (Sigma‐Aldrich) as previously 
described (109). Toluene mounting solution (Permount; Thermo Fisher Scientific) was added to 
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coverslips before placing on top of each slide. Slides were left to dry before imaging. After 
staining, slides were imaged using an Olympus IX81 microscope with a DP2‐Twain color 
camera (Olympus America, Center Valley, PA) and the CellSens Imagining Software 
(Olympus). 
5.3.8 Statistics 
Statistical analysis was performed using GraphPAD Prism (La Jolla, CA). Unless noted, 
data are represented as mean ± standard deviation of at least 3 independent experiments. Data 
were analyzed using one- or two-way ANOVA with Sidak post-hoc testing for pre-specified 
comparisons. A value of α < 0.05 was considered significant.  
5.4 RESULTS 
5.4.1 Enhanced hydrogel degradability accelerates vessel formation in vitro 
 We first optimized our hydrogel formulations to produce acellular hydrogels with shear 
moduli of ~200 Pa and assessed differences in proteolytic degradation depending on crosslink 
Figure 5.1: 2xVPMS hydrogels have increased proteolytic susceptibility compared to VPMS 
hydrogels. Hydrogels were crosslinked, swollen in PBS overnight, exposed to collagenase (1 U/mL), 
and at indicated times, characterized by shear rheology. Hydrogels crosslinked with either peptide 
were readily degradable as measured by shear rheology. #: p < 0.05 relative to collagenase treatment 
(same peptide and time point). *: p < 0.05 compared with 2xVPMS peptide (same treatment and time 
point). N = 3 
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identity. Hydrogels crosslinked with either peptide showed significant decreases in shear 
modulus over time when incubated with collagenase, indicating hydrogel degradation (Fig 5.1). 
Hydrogels crosslinked with 2xVPMS had significantly lower shear moduli than VPMS 
hydrogels at 1.5 hrs, indicating accelerated degradation (Fig 5.1). 
  Acellular hydrogel formulations yielding ~200 Pa hydrogels were chosen to account for a 
significant drop in hydrogel shear modulus to ~100 Pa with incorporation of cell pellets (Fig 5.2 
A). Cellular hydrogels with ~100 Pa shear moduli were empirically targeted to minimize 
modulus, which facilitates vessel formation, while still maintaining enough integrity to handle 
for surgical implantation.  
Figure 5.2: Enhanced crosslink proteolytic susceptibility results in increased vessel density. 
Cellular hydrogel constructs were formed with either VPMS or 2xVPMS crosslinkers and cultured for 
8 days. A) The shear storage modulus (G’) of constructs was determined after overnight culture (day 
1) and on day 8. B) Vessel density in the bulk of the constructs was estimated as described in the 
methods. C) Cell density in the constructs on day 1 and day 8 was quantified from DAPI stained 
images. D) Representative images of maximum intensity projections of confocal sections (z height = 
200 µm) for ECs stained with UEA (red) on Day 8 from constructs formed with either crosslinker 
(vessel density of specific image is shown). *: p < 0.05, relative to VPMS (same day); &: p < 0.01 
relative to day 1 (same crosslinker), N = 5. 
92 
 
 Vessel density significantly increased over time for both VPMS and 2xVPMS hydrogels, 
with a significantly higher average vessel density in 2xVPMS hydrogels (85 ± 8 mm/mm³) 
compared to VPMS hydrogels (65 ± 11 mm/mm³) on day 8 (Fig 5.2 B). The overall nuclei 
density for both VPMS and 2xVPMS hydrogels also significantly increased over time, but no 
significant difference was observed depending on crosslink identity (Fig 5.2 C). Representative 
images of near average vessel formation are shown in Fig 5.2 D, with quantification of the vessel 
density for each specific image shown, to qualitatively illustrate the differences in vessel 
formation observed.  
5.4.2 Enhanced hydrogel degradability improves vessel formation and cell spreading in 
subcutaneous implants, but morphogenesis is severely restricted compared to in vitro. 
 In a preliminary study, intact hydrogels were implanted in subcutaneous pockets on the 
dorsal flank of 6-8 week old CB17-SCID mice to assess whether differences in hydrogel 
degradability affected cellular morphogenesis in vivo. An example of the surgical site and 
implants immediately after surgery is shown in Fig 5.3 A. Overall cell spreading and vessel 
formation was qualitatively assessed by whole mount confocal imaging of UEA, DAPI, and 
phalloidin stained explants and compared to paired in vitro samples (Fig 5.3 B).  Subcutaneous 
implants demonstrated some degree of vessel formation as indicated by elongated UEA-positive 
cells, and fibroblast cell spreading as indicated by UEA-negative phalloidin stained cells. Cell 
spreading and vessel formation in implants appeared more pronounced in 2xVPMS hydrogels 
compared to VPMS hydrogels but neither condition supported the robust interconnected network 
formation observed in in vitro culture for either type of hydrogel (Fig 5.3 B). 
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Figure 5.3: Enhanced hydrogel degradability improves vessel formation and cell spreading in 
subcutaneous implants, but morphogenesis is severely restricted compared to in vitro. Paired 
VPMS and 2xVPMS hydrogels were either implanted subcutaneously on day 1 for 7 days or cultured 
in vitro for 8 days. A) The surgical site immediately after hydrogel implantation. B) Representative 
images of maximum intensity projections of confocal sections (z height = 200 µm) for ECs stained 
with UEA (red), all nuclei stained with DAPI (cyan) and cell bodies stained with phalloidin (green) 
with comparison between paired hydrogels. N = 1. 
Figure 5.4: Cell spreading and vessel-like structures appear in H &E stained explant sections, but 
variable hydrogel collapse during processing precluded comparison depending on crosslinker. 
Paired explants were paraffin embedded, sectioned (10 µm thick) and stained with hematoxylin and 
eosin (H&E). Cell spreading and vessel-like structures were evident in the VPMS explant (A-C). 
Hydrogel collapse of the 2xVPMS explant (D-F) during paraffin embedding was evident 
macroscopically (D) and microscopically (E, F) distorting cellular structures (F). Progressive insets are 
outlined by dashed boxes for A, B, & C and for D, E, & F. Insets B and E have different digital 
magnifications. 
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 In addition to whole mount imaging, cell spreading and formation of vessel-like 
structures was assessed with hematoxylin and eosin (H&E) stained sections of paraffin 
embedded explants (Fig 5.4). Some degree of cell spreading and vessel formation was evident 
throughout explant sections (Fig 5.4 A-C), as was seen in whole mount imaged explants (Fig 5.3 
B). No evidence of red blood cells, indicative of inosculation with the host, was observed within 
the hydrogel implant. Hydrogel collapse of the 2xVPMS hydrogel (Fig 5.4 D-F) precluded 
comparison depending on crosslink identity. Hydrogel collapse was apparent from the 
macroscopic shape change of implant (Fig 5.4 D) and microscopic banding patterns (Fig 5.4 
E,F). The macroscopic shape change and banding patterns were observed on sections throughout 
the thickness of the sample, indicating collapse occurred during dehydration and embedding 
rather than during sectioning (data not shown).  
 
Figure 5.5: Minimal host infiltration is observed in an acellular VPMS implant. The acellular 
explant was paraffin embedded, sectioned (10 µm thick) and stained with hematoxylin and eosin 
(H&E). A) The implant appears largely devoid of cell bodies except for a single cellular protrusion 
from the skin and some infiltrating basophilic cells near the muscle. The region of the implant 
containing cellular infiltration is shown in (B), with cells indicated with black arrows in (C) and (D). 
Progressive insets are indicated with dashed boxes, the respective insets of (B) are indicated. 
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 Histological assessment of an H&E stained acellular VPMS implant indicated minimal 
host cell invasion during the 7 days implanted (Fig 5.5). Coincidently, processing artifacts of the 
paired 2xVPMS acellular hydrogel precluded its assessment as occurred for the cellular hydrogel 
(data not shown). The implant appeared largely devoid of cellular infiltrate except for isolated 
highly basophilic cell bodies near the muscle (Fig 5.5 A-C) and a single continuous cellular 
protrusion emanating from the skin (Fig 5.5 A, B, D).  
 An eosinophilic layer with high cell density between the implant and host tissue was 
observed in some histological sections indicating a fibrous capsule may be forming (Fig 5.6). 
This capsule-like structure was not apparent in all sections, but occurred in sections of both 
acellular and cellular hydrogels. When observed, the capsule-like structure appeared most 
prominent adjacent to intact muscle (data not shown). 
  
5.5 DISCUSSION  
These results demonstrate that increasing the proteolytic susceptibility of PEG-based 
hydrogels by incorporating multiple repeats of a proteolytic recognition sequence into the 
peptide crosslinker is a convenient means of increasing vascular network self-assembly. These 
Figure 5.6: Possible fibrous capsule formation around hydrogel implants.  In some paraffin 
embedded, hematoxylin and eosin (H&E) stained sections, an eosinophilic layer with high cell density 
between the implant and host tissue suggested potential fibrous capsule formation. 
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results are broadly applicable to tissue engineering applications in which acceleration of 
morphogenetic processes in peptide-crosslinked hydrogels is desirable. Proposed applications of 
similar synthetic hydrogels which may benefit from accelerated morphogenesis of encapsulated 
cells include the repair of brain tissue following stroke (232), cardiac repair following ischemia 
reperfusion (233), fabrication of tissue engineered heart valves (234), revascularization of 
ischemic tissue (235), and to enhance angiogenic ingrowth of therapeutic organoids (121). 
Incorporating multiple repeats of the proteolytic recognition sequence is not expected to 
significantly alter the hydrogel network structure. The VPMS crosslinker contains 16 residues 
compared to 24 residues for 2xVPMS. The contour length of a peptide in solution is 
approximately 4 ± 0.2 Å per residue (236) and the length of a 5 kDa PEG molecule has been 
estimated at 355 ± 45 Å (237). These measurements imply the length between the centers of 
adjacent crosslinked PEG molecules is ~77.4 nm compared to ~ 80.6 nm for VPMS and 
2xVPMS crosslinked hydrogels if fully extended.  Moreover, a similar study of PEG hydrogels 
in which a single recognition sequence was compared to a triple repeat (713 and 1889 g/mol, 
respectively) demonstrated  no significant effect on hydrogel properties (91) despite being a 
larger difference in crosslinker MW than VPMS compared to 2xVPMS (1738 and 2554 g/mol). 
Moreover, the initial hydrogel mechanical properties for VPMS and 2xVPMS hydrogels were 
tightly controlled, demonstrating that the enhanced vessel formation in 2xVPMS hydrogels was 
due to differences in proteolytic susceptibility rather than changes in mechanics or network 
structure.   
Although co-cultures in both VPMS and 2xVPMS hydrogels demonstrated increased 
total nuclei densities over time, there was no significant differences depending on crosslink 
identity. This suggests that differences in vessel formation were not attributable to differences in 
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cellular proliferation. Possible explanations for differences in vessel formation without 
differences in cellular proliferation may be due to enhanced cell spreading or migration in 
2xVPMS hydrogels during network self-assembly. 
Hydrogel mechanics were tracked over time to assess whether enhanced proteolytic 
susceptibility negatively affected hydrogel integrity during culture. On the contrary, enhanced 
matrix degradability resulted in a stiffer matrix after in vitro culture. Both VPMS and 2xVPMS 
hydrogels stiffened over time, with 2xVPMS hydrogels stiffening significantly more than 
VPMS. Cellular remodeling processes associated with this stiffening behavior are thoroughly 
investigated in Chapter 6 of this dissertation, but briefly; they depend on active cellular 
contractility and correlate with enhanced collagen deposition and the degree of network 
formation (238). 
A preliminary study of hydrogels implanted in a subcutaneous pocket suggested that 
enhanced hydrogel degradability may support improved vessel formation and cell spreading in 
vivo, but morphogenesis is severely restricted compared to in vitro. CB17/SCID mice were 
chosen because they lack T and B cells resulting in a deficient acquired immune system, 
allowing them to accept foreign tissue transplants. Myelopoiesis and the innate immune system, 
however, remain intact (239) allowing for cellular invasion of tissue implants. Implantation of 
intact hydrogels, rather than injection of hydrogel precursor solutions for in situ gelation as has 
been done before (114), was chosen for precise control of hydrogel mechanics. PEG hydrogel 
mechanics strongly affect degree of vessel formation (231), and need to be controlled to 
accurately assess differences depending on crosslink identity. PEG hydrogel gelation and 
resultant mechanics are very sensitive to impurities, as demonstrated by the 2-fold reduction of 
material properties with incorporation of a cell pellet. As such, the mechanics may be difficult to 
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control with in situ gelation because of stochastic differences in incorporated impurities between 
implant sites.    
Whole mount confocal imaging of explanted hydrogels suggested that cell spreading and 
formation of vessel-like structures was more pronounced in a 2xVPMS hydrogel than its paired 
VPMS hydrogel. There, however, was no robust interconnected network formation as observed 
in their paired in vitro controls. Whole mount confocal imaging of explants provides assessment 
of the 3D structure of networks formed during implantation and allows direct comparison 
between in vivo and in vitro samples. Moreover, whole mount imaging avoids processing 
artifacts associated with hydrogel embedment necessary for histological sectioning, which are 
well-known to deform synthetic hydrogels (240–242). Substantial processing artifacts were 
evident in the histological assessment of some the hydrogel implants. Coincidently, processing 
artifacts for both the acellular and cellular 2xVPMS implants precluded comparison to their 
paired VPMS implants. Sections from the VPMS implants, however, were useful for 
qualitatively evaluating the presence of host infiltration into the acellular hydrogel and a 
potential foreign body response to the implant. Highly basophilic cells appeared to infiltrate the 
PEG implant on the surface adjacent to the muscle. These cells appeared morphologically similar 
to granulocytes, but further histological analysis would be needed to assess their identity. There 
also appeared to be a single continuous cellular projection emanating from the skin. Cellular 
invasion into similar hydrogels in subcutaneous pockets have been demonstrated, with a high 
density of cells infiltrating a VPMS-crosslinked PEG hydrogel up to 400 µm away from the 
tissue interface after 12 weeks in one study (123) and vascularized tissue projections from 
surrounding tissue into a proteolytically degradable PEG hydrogel observable at 14 days in 
another study (134). The ostensive foreign body response to our hydrogel implants may have 
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contributed to the relatively restricted morphogenesis and minimal integration with the host. The 
foreign body response to non-degradable, high density (200 mg/ml) PEG-hydrogels in a 
subcutaneous implant model in immunocompetent mice has previously been assessed and 
extensive fibrous capsule formation was observed (243). This inflammatory response was 
dependent on inflammatory protein adhesion, but was reduced when RGD was conjugated to the 
hydrogel (244).  
Although no inosculation with the host was observed in our preliminary study after 1 
week, angiogenic invasion and perfusion of similar VPMS hydrogels containing pancreatic 
islets, but no endothelial or stromal cells, has been shown to occur in 5 weeks (121). Moreover, 
angiogenic invasion of MMP-degradable PEG hydrogels has been significantly improved with 
cell demanded release of VEGF from implants (106, 107, 121) and fibroblasts have been 
demonstrated to secrete VEGF in vitro (52, 245). These previous studies suggest that despite 
possible capsule formation, angiogenic invasion and inosculation may be feasible at longer time 
points in this subcutaneous implant model. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
